10-Q

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

[X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended.................................................November 30, 2013

OR

[   ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from..........................to.............................

AURA SYSTEMS, INC.

(Exact name of Registrant as specified in its charter)

Delaware	95-4106894
(State or other jurisdiction	(I.R.S. Employer Identification No.)
of incorporation or organization)

4000 Redondo Beach Ave., Suite 101

Redondo Beach, California 90278

(Address of principal executive offices)

Registrant's telephone number, including area code: (310) 643-5300

Former name, former address and former fiscal year, if changed since last report:

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:         YES [ X ]  NO [   ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).         YES [ X ]  NO [   ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated file, a non-accelerated filer, or a smaller reporting company (as defined in Rule 12b-2 of the Act).

Large Accelerated Filer 	Accelerated Filer 
Non-accelerated filer 	Smaller Reporting Company [x]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes  No [x]

1

APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes  No

Indicate the number of shares outstanding of each of the issuer's classes of Common Stock, as of the latest practicable date.

Class	Outstanding January 6, 2014
Common Stock, par value $0.0001 per share	88,414,499 shares

2

AURA SYSTEMS, INC.

INDEX

Index			Page No.
PART I.	FINANCIAL INFORMATION
	ITEM 1.	Financial Statements (Unaudited)
		Condensed Balance Sheets as of November 30, 2013 and February 28, 2013	4
		Condensed Statements of Operations for the Three and  Nine Months Ended November 30, 2013 and 2012	5
		Condensed Statements of Cash Flows for the Nine Months Ended November 30, 2013 and 2012	6
		Notes to Condensed Financial Statements	7
	ITEM 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	15
	ITEM 4.	Controls and Procedures	20
PART II.	OTHER INFORMATION
	ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	21
	ITEM 6.	Exhibits	21
	SIGNATURES AND CERTIFICATIONS		22

3

PART I.  FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

AURA SYSTEMS, INC.

CONDENSED BALANCE SHEETS

(Unaudited)

	November 30, 2013			February 28, 2013
ASSETS
Current assets:
Cash and cash equivalents	$	57,906		$	89,196
Accounts receivable, net of allowance for doubtful accounts of $50,000 at November 30, 2013 and February 28, 2013		572,652			279,551
Inventory - current		1,000,000			1,000,000
Other current assets		254,550			235,034
Total current assets		1,885,108			1,603,780
Deposits		89,988			61,944
Property, plant, and equipment, net		11,948			40,470
Inventory, non-current, net of allowance for obsolete inventory of $1,203,431 and $1,341,650 at November 30, 2013 and February 28, 2013,  respectively		1,214,200			1,384,142
Total assets	$	3,201,244		$	3,090,336
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable	$	1,560,034		$	1,202,382
Accrued expenses		2,273,523			1,601,740
Customer advances		72,080			12,598
Notes payable		1,534,990			3,004,990
Convertible notes payable, net of discount		2,361,592			503,509
Notes payable and accrued interest- related party		19,144,583			17,265,466
Total current liabilities		26,946,801			23,590,684
Convertible note payable, net of discount		1,165,184			1,097,938
Convertible note payable and accrued interest-related party, net of discount		1,889,103			-
Total liabilities		30,001,088			24,688,623
Commitments
Stockholders' deficit:
Common stock, $0.0001 par value; 150,000,000 shares authorized at November 30, 2013 and February 28, 2013; 88,414,499 and 76,604,573 issued and outstanding at November 30, 2013 and February 28, 2013, respectively		8,841			7,660
Additional paid-in capital		403,040,092			398,949,767
Accumulated deficit		(429,848,777	)		(420,555,713	)
Total stockholders' deficit		(26,799,844	)		(21,598,286	)
Total liabilities and stockholders' deficit	$	3,201,244		$	3,090,336

See accompanying notes to these unaudited condensed financial statements.

4

AURA SYSTEMS, INC.

CONDENSED STATEMENTS OF OPERATIONS

FOR THE THREE AND NINE MONTHS ENDED NOVEMBER 30, 2013 AND 2012

(Unaudited)

	Three Months						Nine Months
	2013			2012			2013			2012
Net Revenues	$	852,534		$	1,215,024		$	2,276,449		$	2,286,496
Cost of goods sold		341,503			644,648			973,458			1,104,674
Gross Profit		511,031			570,376			1,302,991			1,181,822
Expenses
Engineering, research and development expenses		387,056			312,262			1,090,756			1,008,954
Selling, general and administrative expenses		1,847,365			3,496,624			6,686,790			8,024,082
Total costs and expenses		2,234,422			3,808,886			7,777,546			9,033,036
Loss from operations		(1,723,391	)		(3,238,510	)		(6,474,555	)		(7,851,214	)
Other (income) and expense
Interest expense, net		859,361			1,009,131			3,031,227			2,834,226
Gain on settlement of debt		-			-			(203,110	)
Other (income) expense, net		-			(2,095,000	)		(9,607	)		(2,103,166	)
Total other (income) expense		859,361			(1,085,869	)		2,818,510			731,060
Net Loss	$	(2,582,751	)	$	(2,152,641	)	$	(9,293,065	)	$	(8,582,274	)
Total basic and diluted loss per share	$	(0.03	)	$	(0.03	)	$	(0.11	)	$	(0.12	)
Weighted average shares used to compute basic and diluted income (loss) per share*		88,414,499			72,750,310			83,517,143			72,381,581

*Weighted average number of shares used to compute basic and diluted loss per share is the samesince the effect of the dilutive securities is anti-dilutive.

See accompanying notes to these unaudited condensed financial statements.

5

AURA SYSTEMS, INC.

CONDENSED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED NOVEMBER 30, 2013 AND 2012

(Unaudited)

	2013			2012
Cash flow from operating activities:
Net Loss	$	(9,293,065	)	$	(8,582,274	)
Adjustments to reconcile Net loss to net cash used in operating activities
Depreciation Expense		28,523			125,783
Bad debt expense		-			(4,227	)
Amortization of debt discount		725,935			1,806,354
(Gain) Loss on settlement of debt		(203,110	)		-
Fair market value of warrants issued for services		333,559			-
Stock issued for services		889,726			316,000
Provision for inventory obsolescence		(138,219	)		(193,972	)
Amortization of prepaid shares		-			393,328
Fair market value of stock options granted		256,680			204,961
(Increase) decrease in: Accounts receivable		(293,101	)		58,304
Inventory		308,161			357,486
Other current assets and deposit		(47,560	)		(248,075	)
Increase (decrease) in:
Accounts payable, customer deposit and accrued expenses		2,203,732			1,624,993
Net cash used in operations		(5,228,740	)		(4,141,339	)
Financing activities:
Issuance of common stock		-			152,000
Proceeds from notes payable		1,171,000			2,671,000
Payments on notes payable		(170,000	)		-
Proceeds from convertible notes payable		1,170,700			-
Payments on  convertible notes payable		(306,250	)		(2,143,750	)
Proceeds from notes payable-related party, net		3,332,000			3,494,960
Net cash provided by financing activities:		5,197,450			4,174,210
Net increase(decrease) in cash & cash equivalents		(31,290	)		32,871
Cash and cash equivalents at beginning of period		89,196			6,260
Cash and cash equivalents at end of period	$	57,906		$	39,131
Supplemental disclosures of cash flow information
Cash paid during the period for:
Interest	$	124,558		$	25,780
Income taxes		-			-

Unaudited supplemental disclosure of non-cash investing and financing activities:

During the Nine Months ended November 30, 2013, $1,330,112 of notes payable and accrued interest were converted into 2,660,225 shares of common stock, 1,833,333 shares of common stock and 916,666 7-year warrants to purchase our stock with an exercise price of $0.75 were issued to re-price a prior issuance of stock in December 2012, and 4,254,250 shares of common stock were issued in exchange for the cancellation of warrants to purchase 5,005,000 shares of  common stock at an exercise price of $0.75 per share which would have expired on September 22, 2016.

See accompanying notes to these unaudited condensed financial statements

6

AURA SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1 - ACCOUNTING POLICIES

Accounting principles

In the opinion of management, the accompanying balance sheets and related interim statements of income and comprehensive income, and cash flows include all adjustments, consisting only of normal recurring items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s 2013 Form 10-K filed on June 12, 2013 with the U.S. Securities and Exchange Commission.

Estimates

The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Recently Issued Accounting Pronouncements

Accounting Standards Update No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists: An unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The assessment of whether a deferred tax asset is available is based on the unrecognized tax benefit and deferred tax asset that exist at the reporting date and should be made presuming disallowance of the tax position at the reporting date. For example, an entity should not evaluate whether the deferred tax asset expires before the statute of limitations on the tax position or whether the deferred tax asset may be used prior to the unrecognized tax benefit being settled. The amendments in this Update do not require new recurring disclosures. ASU Topic No. 2013 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

Accounting Standards Update No. 2013-05, Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity: This ASU addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. ASU Topic No. 2013-05 is effective for our fiscal year 2014, although early adoption is permitted. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

In March 2013, the FASB issued guidance on a parent’s accounting for the cumulative translation adjustment upon derecognition of a subsidiary or group of assets within a foreign entity. This new guidance requires that the parent release any related cumulative translation adjustment into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided. The new guidance will be effective for the Company beginning July 1, 2014. The adoption of this standard is not expected to have a material impact on the Company’s financial statements.

7

In February 2013, the FASB issued ASU No. 2013-02, which amends the authoritative accounting guidance under ASC Topic 220 Comprehensive Income.  The amendments do not change the current requirements for reporting net income or other comprehensive income in financial statements.  However, the amendments require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.  In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period.  For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about those amounts.  The amendments in this update are effective prospectively for reporting periods beginning after December 15, 2013.  Early adoption is permitted.  Adoption of this update is not expected to have a material effect on the Company’s consolidated results of operations or financial condition.

Reclassifications

Certain reclassifications have been made to the comparative financial statements to conform to the current period presentation.

NOTE 2 – GOING CONCERN

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern.  During the Nine Months ended November 30, 2013 and November 30, 2012, the Company incurred losses of $9,293,065 and $8,582,274, respectively and had negative cash flows from operating activities of $5,228,740 and $4,141,339, respectively.

If the Company is unable to generate profits and is unable to continue to obtain financing for its working capital requirements, it may have to curtail its business sharply or cease business altogether.

Substantial additional capital resources will be required to fund continuing expenditures related to our research, development, manufacturing and business development activities.  The Company's continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to retain its current financing, to obtain additional financing, and ultimately to attain profitability.

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that could result from the outcome of this uncertainty.

NOTE 3 – INVENTORIES

Inventories, stated at the lower of cost (first in first out), or market consisted of the following:

	November 30, 2013			February 28, 2013
Raw materials	$	1,882,853		$	1,888,831
Finished goods		1,534,778			1,836,960
		3,417,631			3,725,791
Reserve for potential product obsolescence		(1,125,929	)		(1,253,300	)
Discount on long term inventory		(77,502	)		(88,350	)
		2,214,200			2,384,141
Non-current portion		(1,214,200	)		(1,384,141	)
Current portion	$	1,000,000		$	1,000,000

We assessed the net realize-ability and the related potential obsolescence of inventory. In accordance with this assessment, management has recorded a reserve of $1,125,929 and $1,253,300 as of November 30, 2013 and February 28, 2013, respectively. Management has also recorded a discount on long term inventory of $77,502 and $88,350 as of November 30, 2013 and February 28, 2013, respectively.

8

NOTE 4 – OTHER CURRENT ASSETS

Other assets of $254,550 and $235,034 are primarily comprised of vendor advances of $173,303 and $181,910 as of November 30, 2013 and February 28, 2013.

NOTE 5 – PROPERTY, PLANT, AND EQUIPMENT

Property, plant, and equipment consisted of the following:

	November 30, 2013			February 28, 2013
Machinery and equipment	$	964,111		$	964,111
Furniture and fixtures		163,302			163,302
Leasehold improvements		-			485,080
		1,127,413			1,612,493
Less accumulated depreciation		(1,115,466	)		(1,572,023	)
Property, plant and equipment, net	$	11,947		$	40,470

Depreciation expense was $28,523 and $125,783 for the Nine Months ended November 30, 2013 and November 30, 2012, respectively. The Company disposed of all of its leasehold improvements in the third quarter when we moved to a new facility. The assets were fully amortized and there was no gain or loss on the disposition.

NOTE 6 – NOTES PAYABLE

Notes payable consisted of the following:

	November 30, 2013		February 28, 2013
Demand notes payable, at 10% and 16%	$	1,534,990	$	3,004,990
Convertible Promissory Note dated August 10, 2012, due August 10, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 10th of each month with the principal payment due on the maturity date.		770,664		724,056
Convertible Promissory Note dated October 2, 2012, due October 2, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 2nd of each month with the principal payment due on the maturity date.		394,520		373,882
Convertible Promissory Note dated November 2, 2012, due January 4, 2013, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 2nd of each month with the principal payment due on the maturity date.		-		350,000
Senior secured convertible note dated September 23, 2011, due March 23, 2013, with 12 monthly payments commencing April 23, 2012 of $306,250 per month. The notes have a stated interest rate of 0%, with prepaid interest of $175,000. Balance net of Beneficial Conversion Feature		-		153,508
Senior secured convertible notes dated May 7, 2013, due June 15, 2013, convertible into shares of our common stock at a price of $0.75 per share. The notes carry an interest rate of 12% with interest due on the last day of the month. If the note is not repaid by the due date, the interest rate increases to 16%.		2,071,584		-
Senior secured convertible notes dated June 20, 2013, due June 20, 2014, convertible into shares of our common stock at a price of $0.75 per share. The notes carry an interest rate of 16% with interest due on the last day of the month. If the note is not repaid by the due date, the interest rate increases to 16%.		290,008		-
		5,061,766		4,606,436
Less: Current portion	$	3,896,582	$	3,508,498
Long-term portion	$	1,165,184	$	1,097,938

9

CONVERTIBLE DEBT

On September 23, 2011, the Company entered into a purchase agreement to sell convertible notes with a total principal value of $3,675,000 and warrants to purchase shares of common stock to an investment fund managed by MDB Capital Group.  The notes have a 1.5 year maturity date and are convertible into shares of common stock at the initial conversion price of $0.75 per share.  The warrants entitle the investors to acquire 4,900,000 and 490,000 shares and have an initial exercise price of $1 and $0.75 per share, respectively, and have a 5 year term. The proceeds of Convertible note were assigned between warrants and convertible note per ASC 470-20. The company recorded $175,000 as a discount (prepaid interest), $1,006,482 as capitalized financing cost and a discount of $1,790,482 on shares to be issued upon conversion of the note into equity. This discount (prepaid interest), capitalized finance cost and discount will be amortized over the life of the note. The notes were repaid in full in March 2013 and the Company then entered into an exchange agreement with the note holders whereby the outstanding warrants held by the investors, which carried an exercise price of $0.75 per share and would expire on September 22, 2016, were exchanged for our Common Stock at a ratio of 0.85 shares of common stock for each warrant outstanding.

On May 7, 2013, the Company transferred 4 notes payable with a total principal value of $1,000,000 together with accrued interest, and consulting fees to a senior secured convertible note with a principal value of $1,087,000 (“new note”) and warrants to Kenmont Capital Partners (the “holder”). The new note has a 1 year maturity date and is convertible into shares of common stock at the conversion price of $0.75 per share, provided, that the Conversion Price shall automatically be reset to $0.50 per share on June 15, 2013 if a Qualified Financing has not occurred on or prior to that date. The warrants entitle the holder to acquire 1,449,333 shares and have an initial exercise price of $0.75 per share, and have a 7 year term. The Company recorded $342,020 as a discount, which will be amortized over the life of the note.

On May 7, 2013, the Company transferred 2 note payables with a total principal value of $550,000 together with accrued interest to a senior secured convertible note with a principal value of $558,700 (“new note”) and warrants to LPD Investments, Ltd. (the “holder”). The new note has a 1 year maturity date and is convertible into shares of common stock at the conversion price of $0.75 per share, provided, that the Conversion Price shall automatically be reset to $0.50 per share on June 15, 2013 if a Qualified Financing has not occurred on or prior to that date. The warrants entitle the holder to acquire 744,933 shares and have an initial exercise price of $0.75 per share, and have a 7 year term. The Company recorded $175,793 as a discount, which will be amortized over the life of the note.

On May 7, 2013, the Company entered into an agreement with an individual (the “holder”) for the sale of $750,000 of secured convertible note payable (the “Note”) and warrants to the holder. The Note has a 1 year maturity date and is convertible into shares of common stock at the conversion price of $0.75 per share, provided, that the Conversion Price shall automatically be reset to $0.50 per share on June 15, 2013 if a Qualified Financing has not occurred on or prior to that date. The warrants entitle the holder to acquire 1,000,000 shares and have an initial exercise price of $0.75 per share, and have a 7 year term. The Company recorded $235,985 as a discount, which will be amortized over the life of the note.

On June 20, 2013, the Company entered into an agreement with four individuals (the “holders”) for the sale of $325,000 of secured convertible notes payable (the “Notes”) and warrants to the holders. The Notes have a 1 year maturity date and are convertible into shares of common stock at the conversion price of $0.50 per share. If the Company receives no less than $5,000,000 in aggregate gross proceeds from the sale of equity securities of the Company in one or series of related transactions after June 20, 2013 (“the Qualified Financing”), the Company shall deliver to each Holder a written offer to issue and sell to or exchange with such Holder such number of securities as is equal to the quotient of (x) the conversion balance of the Note divided by (y) 100% of the purchase price of the primary securities offered to investors pursuant to the Qualified Financing. The warrants entitle the holders to acquire 433,334 shares and have an initial exercise price of $0.75 per share, and have a 7 year term. The Company recorded $63,622 as a discount, which will be amortized over the life of the notes.

10

On August 19, 2013, the Company entered into an agreement with a member of its Board of Directors for the sale of $2,500,000 of convertible notes payable (the “Notes”) and warrants to the holder. The notes carry a base interest rate of 9.5%, have a 4 year maturity date and are convertible into shares of common stock at the conversion price of $0.50 per share. The warrants entitle the holder to acquire 5,000,000 shares and have an initial exercise price of $0.75 per share and have a 7 year term. The Company recorded $667,118 as a discount, which will be amortized over the life of the note.

Future maturities of notes payable at November 30, 2013 are as follows:

Year Ending February 28,
2014	$	-
2015		-
2016		-
2017		3,054,287
Total	$	3,054,287

CONVERTIBLE PROMISSORY NOTES

At February 28, 2013, the three other convertible promissory note payable amounted to $1,447,938, net of discounts of $402,063. The convertible notes (the “Notes”) bear interest at 7% per annum, and are convertible into common stock of the Company at $0.76 per share (as well as variable conversion rates as described below). The notes are due on August 10, 2017, October 2, 2017, and January 4, 2013 and are unsecured. On May 7, 2013, the note due on January 4, 2013 was converted into a portion of the note due June 15, 2013, which carries an interest rate of 12%.

7% Convertible Promissory Notes:

On August 10, 2012 the Company entered into an agreement with the individual (the “holder”) for the sale of $1,000,000 of unsecured Convertible Promissory Note (the “Note”) to the holder. The Convertible Promissory Note balance together with all accrued interest thereon shall be due and payable on August 10, 2017 and the annual interest rate is 7% per annum and is due to be repaid 5 years from the closing date.  The Note holder will receive interest on the unpaid principal amount payable monthly in arrears on the tenth day of each calendar month commencing September 10, 2012. Interest shall be computed on the actual number of days elapsed over a 360-day year. The Holder has the right from and after the Date of Issuance, and until any time until the Convertible promissory note is fully paid, to convert any outstanding and unpaid principal portion of the Convertible promissory note into shares of Common Stock. The company recorded $310,723 as a debt discount, which will be amortized over the life of the note.

On October 2, 2012 the Company entered into an agreement with the individual (the “holder”) for the sale of $500,000 of unsecured Convertible Promissory Note (the “Note”) to the holder. The Convertible Promissory Note balance together with all accrued interest thereon shall be due and payable on October 2, 2017 and the annual interest rate is 7% per annum and is due to be repaid 5 years from the closing date.  The Note holder will receive interest on the unpaid principal amount payable monthly in arrears on the second day of each calendar month commencing November 2, 2012. Interest shall be computed on the actual number of days elapsed over a 360-day year. The Holder has the right from and after the Date of Issuance, and until any time until the Convertible promissory note is fully paid, to convert any outstanding and unpaid principal portion of the Convertible promissory note into shares of Common Stock. The company recorded $137,583 as a debt discount, which will be amortized over the life of the note.

On November 2, 2012 the Company entered into an agreement with the individual (the “holder”) for the sale of $350,000 of unsecured Convertible Promissory Note (the “Note”) to the holder. The Convertible Promissory Note balance together with all accrued interest thereon shall be due and payable on January 4, 2013 and the annual interest rate is 7% per annum and is due to be repaid 2 months from the closing date.  The Note holder will receive interest on the unpaid principal amount payable monthly in arrears on the second day of each calendar month commencing December 2, 2012. Interest shall be computed on the actual number of days elapsed over a 360-day year. The Holder has the right from and after the Date of Issuance, and until any time until the Convertible promissory note is fully paid, to convert any outstanding and unpaid principal portion of the Convertible promissory note into shares of Common Stock. On May 7, 2013, this note was converted into a portion of the note due June 15, 2013, which carries an interest rate of 12%.

11

The Convertible Notes have a variable conversion price. If, at any time while the Notes remain outstanding, the Company issues or sells any Convertible Securities and the lowest price per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof is less than the then Conversion Price of the Notes (such lower price, the "Dilutive Price"), then the Conversion Price of these Notes shall be adjusted to reflect such Dilutive Price. Such adjustment shall be made upon the issuance or sale of the Convertible Security bearing a dilutive price. In the event of default for the Notes, the amount of principal and interest not paid when due becomes immediately due and payable.

NOTE 7 - ACCRUED EXPENSES

Accrued expenses consisted of the following:

	November 30, 2013		February 28, 2013
Accrued payroll and related expenses	$	2,042,474	$	1,564,496
Accrued rent		145,927		4,292
Accrued interest		79,946		30,867
Other		5,176		2,085
Total	$	2,273,523	$	1,601,740

Accrued payroll and related expenses consisted primarily of salaries accrued but not paid to certain employees. As of November 30, 2013 and February 28, 2013, these amounts total $1,446,640 and $927,984, respectively. Also included in this amount is accrued vacation expense of $462,687 and $411,667 at November 30, 2013 and February 28, 2013, respectively.

NOTE 8–SHAREHOLDERS’ EQUITY

Common Stock

During the Nine Months ended November 30, 2013, $1,330,112 of notes payable and accrued interest were converted into 2,660,225 shares of common stock, 595,451 shares of common stock were issued for services and expenses related to the notes valued at $297,726, 1,833,333 shares of common stock were issued to re-price a prior issuance of stock in December 2012, 1,266,667 shares valued at $304,000 and 1,000,000 warrants valued at $133,424 were issued as a settlement for failure to repay a $500,000 note when due, 700,000 shares valued at $168,000 and 700,000 warrants valued at $93,397 were issued as consideration for issuing a letter of credit for $350,000 on Aura’s behalf, 500,000 shares valued at $120,000 and 800,000 warrants valued at $106,739 were issued to an individual as consideration for joining Aura’s Board of Directors and 4,254,250 shares of common stock were issued in exchange for the cancellation of warrants to purchase 5,005,000 shares of common stock at an exercise price of $0.75 per share which would have expired on September 22, 2016.

During the nine months ended November 30, 2012, we issued 415,789 shares of Common Stock for services rendered valued at $316,000, 200,000 shares of common stock for consideration of $152,000, and 341,748 shares upon conversion of $259,729 of notes payable and accrued interest.

Employee Stock Options

During the Nine Months ended November 30, 2013 we granted 233,333 options as a performance bonus to our Vice-President of sales and 7,000 options to other employees.

12

In September, 2006, our Board of Directors adopted the 2006 Employee Stock Option Plan. Activity in this plan is as follows:

	2006 Plan
		Weighted-Average Exercise Price	Aggregate Intrinsic Value	Number of Options
Outstanding, February 28, 2013		$0.75-$1.00	$0.00	8,548,000
Cancelled		-	-	-
Granted		$0.75	$0.00	240,333
Outstanding, November 30, 2013		$0.75-$1.00	$0.00	8,788,333

The exercise prices for the options outstanding at November 30, 2013, and information relating to these options is as follows:

Options Outstanding

Exercisable Options

Range of Exercise Price

Number

Weighted Average Remaining Life

Weighted Average Exercise Price

Weighted Average Remaining Life

Number

Weighted Average Exercise Price

$0.75-$1.00

8,788,333

6.15 years

$

0.79

6.25years

8,421,666

$

0.79

Warrants

Activity in issued and outstanding warrants is as follows:

	Number of Shares			Exercise Prices
Outstanding, February 28, 2013		38,783,290		$	0.75-$3.00
Granted		12,262,096		$	0.75
Cancelled/Expired		(5,025,000	)	$	0.75
Outstanding, November 30, 2013		46,020,386		$	0.75-$3.00

The exercise prices for the warrants outstanding at November 30, 2013, and information relating to these warrants is as follows:

Range of Exercise Prices	Stock Warrants Outstanding	Stock Warrants Exercisable	Weighted-Average Remaining Contractual Life	Weighted-Average Exercise Price of Warrants Outstanding	Weighted-Average Exercise Price of Warrants Exercisable	Intrinsic Value
$0.75	8,893,334	8,893,334	80 months	$0.75	$0.75	$0.00
$0.75	3,368,762	3,368,762	77 months	$0.75	$0.75	$0.00
$0.75-$1.00	8,756,942	8,756,942	68 months	$0.81	$0.81	$0.00
$1.00-$1.25	1,220,000	1,220,000	34 months	$1.03	$1.03	$0.00
$1.00	16,722,787	16,722,787	33 months	$1.00	$1.00	$0.00
$1.50	155,000	155,000	28 months	$1.50	$1.50	$0.00
$0.75-1.50	1,109,198	1,109,198	25 months	$1.17	$1.17	$0.00
$1.50	156,000	156,000	21 months	$1.50	$1.50	$0.00
$1.50	704,000	704,000	20 months	$1.50	$1.50	$0.00
$1.50	350,642	350,642	17 months	$1.50	$1.50	$0.00
$0.75-$2.00	58,000	58,000	13 months	$1.78	$1.78	$0.00
$2.00	725,721	725,721	10 months	$2.00	$2.00	$0.00
$0.75-2.00	3,650,000	3,650,000	7 months	$1.03	$1.03	$0.00
$3.00	150,000	150,000	.5 months	$3.00	$3.00	$0.00
	46,020,386	46,020,386

13

NOTE 9 –INCOME TAXES

Our effective tax rates were approximately 0.0% for the Nine Months ended November 30, 2013 and 2012. Our effective tax rate was lower than the U.S. federal statutory rate primarily due to the fact that we record a full valuation allowance against our deferred tax assets, which is primarily comprised of net operating losses.

NOTE 10 - SEGMENT INFORMATION

We are a United States based company providing advanced technology products to various industries. The principal markets for our products are North America, Europe, and Asia.  All of our operating long-lived assets are located in the United States. We operate in one segment.

Total net revenues from customer geographical segments are as follows for the Nine Months ended November 30, 2013 and 2012:

	2013		2012
United States	$	1,451,188	$	1,488,536
Canada		136,097		76,197
Europe		44,503		54,261
Asia		635,780		631,058
Other		8,881		36,444
Total	$	2,276,449	$	2,286,496

NOTE 11 – SIGNIFICANT CUSTOMERS

Concentration Risk

In the Nine Months ended November 30, 2013, we sold AuraGen related products to three significant customers whose sales comprised 27.4%, 24.8% and 10.0% of net sales, respectively. Net accounts receivable from these customers at November 30, 2013 were $173,430, $0 and $194,250 respectively. These customers are not related to or affiliated with us. In the nine months ended November 30, 2012, we sold AuraGen related products to three significant customers whose sales comprised 26%, 18% and 17% of net sales, respectively. Net accounts receivable from these customers at November 30, 2012 were $83,388, $419,321and $102,585 respectively. These customers are not related to or affiliated with us.

14

NOTE 12 – RELATED PARTIES TRANSACTIONS

At November 30, 2013, the balance in Notes Payable and accrued interest-related party, current, includes $13,819,960 of unsecured notes payable plus accrued interest of $4,478,153 to a member of our Board of Directors, payable on demand, bearing interest at a rate of 10% per annum. During the Nine Months ended November 30, 2013 and November 30, 2012, interest amounting to $1,032,647 and $960,078 respectively, was incurred on these notes. The balance also includes $82,000 of unsecured notes payable plus accrued interest of $5,319 to our CEO pursuant to a demand note entered into on April 5, 2013 and an unsecured note payable to another member of our Board of Directors in the amount of $750,000 plus accrued interest of $9,151 pursuant to a 10% demand note payable entered into on October 17, 2013. At November 30, 2013, the balance in Convertible note payable and accrued interest-related party, long term, includes $1,880,517 of secured notes payable net of discounts of $619,483 plus accrued interest of $8,586 to another member of our Board of Directors. The Company also issued the following stock and warrants to this board member: 1,833,333 shares of our common stock and 916,666 7 year warrants with an exercise price of $0.75 as a re-pricing of a previous issuance made in December 2012, 1,266,667 shares of our common stock and 1,000,000 7 year warrants with an exercise price of $0.75 for failure to repay a $500,000 note when due, 700,000 shares of our common stock and 700,000 7 year warrants with an exercise price of $0.75 for issuing a $350,000 letter of credit on Aura’s behalf,  500,000 shares of our common stock and 800,000 7 year warrants with an exercise price of $0.75 for joining Aura’s Board of Directors, and 5,000,000 7 year warrants attached to the $2,500,000 convertible note which includes the unpaid $500,000 note referred to above.

NOTE 13 – COMMITMENTS

In September, 2014, we entered into a lease for a facility of approximately 69,000 square feet.  The lease is for a term of seven years, has an option to extend for five years, and carries an initial base rent of $46,871.72.  In accordance with the terms of the lease, the Company is responsible for common area charges.

 ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Statements

This Report contains forward-looking statements within the meaning of the federal securities laws.  Statements other than statements of historical fact included in this Report, including the statements under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” regarding future events or prospects are forward-looking statements. The words “approximates,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans” “would  “should,” “may,” or other similar expressions in this Report, as well as other statements regarding matters that are not historical fact, constitute forward-looking statements. We caution investors that any forward-looking statements presented in this Report are based on the beliefs of, assumptions made by, and information currently available to, us. Such statements are based on assumptions and the actual outcome will be affected by known and unknown risks, trends, uncertainties and factors that are beyond our control or ability to predict. Although we believe that our assumptions are reasonable, they are not guarantees of future performance and some will inevitably prove to be incorrect. As a result, our actual future results may differ from our expectations, and those differences may be material. Accordingly, investors should use caution in relying on forward-looking statements to anticipate future results or trends.

Some of the risks and uncertainties that may cause our actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements include the following:

·   Our ability to generate positive cash flow from operations;

·   Our ability to obtain additional financing to fund our operations;

·   Our business development and  operating development; and

·   Our expectations of growth in demand for our products.

For further information regarding these and other risks and uncertainties, we refer you to Part I, Item 1A of our Form 10-K for the fiscal year ended February 28, 2013.

We do not intend to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise except to the extent required by law. You should interpret all subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf as being expressly qualified by the cautionary statements in this Report. As a result, you should not place undue reliance on these forward-looking statements.

15

Overview

We design, assemble and sell the AuraGen®, our patented mobile power generator that uses a prime mover such as the engine of a vehicle to generate power. The AuraGen® delivers on-location, plug-in electricity for any end use, including industrial, commercial, recreational and military applications. We began commercializing the AuraGen® in late 1999 and sold our first commercial units in late 2000 and early 2001. To date, AuraGen® units have been sold in numerous industries, including recreational, utilities, telecommunications, emergency/rescue, public works, catering, oil and gas, transportation, government and the military.

We have not yet achieved a level of AuraGen® sales sufficient to generate positive cash flow. Accordingly, we have depended on repeated infusions of cash in order to maintain liquidity as we have sought to develop sales.

Our financial statements included in this report have been prepared on the assumption that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. However, as a result of our losses from operations, there is substantial doubt about our ability to continue as a going concern. Our independent auditors, in their report on the Company’s financial statements for the year ended February 28, 2013 expressed substantial doubt about the Company’s ability to continue as a going concern.   The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amount and classification of liabilities that may result from our possible inability to continue as a going concern.

Our ability to continue as a going concern is dependent upon the successful achievement of profitable operations, and the ability to generate sufficient cash from operations and obtain financing resources to meet our obligations.  There is no assurance that such efforts will be successful.

Our current level of sales reflects our efforts to introduce a new product into the marketplace. Until recently, many purchases of the product were for evaluation purposes. Recently we started to receive repeat orders for larger quantities as different organizations are integrating our products into their vehicles. We seek to achieve profitable operations by obtaining market acceptance of the AuraGen® as a competitive - if not superior - product providing mobile power anywhere anytime. There can be no assurance that this success will be achieved.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of financial statements requires management to make estimates and disclosures on the date of the financial statements. On an on-going basis, we evaluate our estimates, including, but not limited to, those related to revenue recognition. We use authoritative pronouncements, historical experience and other assumptions as the basis for making judgments. Actual results could differ from those estimates. We believe that the following critical accounting policies affect our more significant judgments and estimates in the preparation of our consolidated financial statements.

Revenue Recognition

We are required to make judgments based on historical experience and future expectations, as to the reliability of shipments made to our customers. These judgments are required to assess the propriety of the recognition of revenue based on Staff Accounting Bulletin ("SAB") No. 101, "Revenue Recognition," and related guidance. Because sales are currently in limited volume and many sales are for evaluative purposes, we have not booked a general reserve for returns. We will consider an appropriate level of reserve for product returns when our sales increase to commercial levels.

16

Inventory Valuation and Classification

Inventories consist primarily of components and completed units for our AuraGen® product. Inventories are valued at the lower of cost (first-in, first-out) or market. Provision is made for estimated amounts of current inventories that will ultimately become obsolete due to changes in the product itself or vehicle engine types that go out of production. We are holding inventories in excess of what we expect to sell in the next fiscal year. The net inventories which are not expected to be realized within a 12-month period based on current sales forecasts have been reclassified as long term. Management believes that existing inventories can, and will, be sold in the future without significant costs to upgrade it to current models and that the valuation of the inventories, classified both as current and long-term assets, accurately reflects the realizable values of these assets. The AuraGen® product being sold currently is not technologically different from those in current use. Existing finished goods inventories can be upgraded to the current model with only a small amount of materials and manpower. We make these assessments based on the following factors: i) existing orders, ii) age of the inventory, iii) historical experience and iv) our expectations as to future sales. If expected sales volumes do not materialize, there would be a material impact on our financial statements.

Valuation of Long-Lived Assets

Long-lived assets, consisting primarily of property and equipment, and patents and trademarks, comprise a portion of our total assets.  Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying values may not be recoverable. Recoverability of assets is measured by a comparison of the carrying value of an asset to the future net cash flows expected to be generated by those assets. Net cash flows are estimated based on expectations as to the realize-ability of the asset. Factors that could trigger a review include significant changes in the manner of an asset’s use or our overall strategy.

Specific asset categories are treated as follows:

Accounts Receivable: We record an allowance for doubtful accounts based on our expectation of collect-ability of current and past due accounts receivable.

Property, Plant and Equipment: We depreciate our property and equipment over various useful lives ranging from five to ten years. Adjustments are made as warranted when market conditions and values indicate that the current value of an asset is less than its net book value.

When we determine that an asset is impaired, we measure any such impairment by discounting an asset’s realizable value to the present using a discount rate appropriate to the perceived risk in realizing such value. When we determine that an impaired asset has no foreseeable realizable value, we write such asset down to zero.

Results of Operations

Nine months ended November 30, 2013 compared to nine months ended November 30, 2012

Net revenues for the nine months ended November 30, 2013 (the “Nine months FY2014”) decreased $10,047 to $2,276,449 from $2,286,496 in the nine months ended November 30, 2012 (the “Nine months FY2013”), a decrease of .4%. Our customers typically order on an as needed basis and therefore our sales can fluctuate substantially between periods based on our customers’ needs at a given time.

Cost of goods decreased $131,216 (11.9%) to $973,458 in the Nine months FY2014 from $1,104,674 in the Nine months FY2013. The decrease in cost of goods is primarily a result of the mix of products sold during the period.

Engineering, research and development expenses increased $81,802 (8%) to $1,090,756 in the Nine months FY2014 from $1,008,954 in the Nine months FY 2013.  In the past, we have reduced our expenditures in this area due (i)our financial situation, and (ii) due to reduced efforts in developments of new configurations.  With major new contracts and customers we now expect our expenditures in this area to increase in the future.

17

Selling, general and administrative expense decreased $1,337,292 (17%) to $6,686,790 in the Nine months FY2014 from $8,024,082 in the Nine months FY2013. The decrease is primarily attributable to a decrease in legal expenses of approximately $1,163,000 and a decrease in marketing expenses of approximately $539,000, partially offset by an increase in non-cash charges of $227,000 for stock issued to a member of our Board of Directors as compensation for joining our Board. The decrease in legal expenses was due to a settlement of a lawsuit against our former bankruptcy attorneys in the amount of $2,095,000 in the Nine months FY2013. Of this amount approximately $1,155,000 in legal expenses were incurred.

Net interest expense in the Nine months FY2014 increased $197,001 (7%) to $3,031,227 from $2,834,226 in the Nine months FY2013 as a result of our increased debt levels and the non-cash amortization of the debt discount and warrant expense of the notes payable entered into in the current year, partially offset by the decrease in the non-cash amortization of the debt discount, warrant expense and beneficial conversion feature on the financing completed in the third quarter of FY2012 which was fully repaid in the first quarter of FY2014.

Other income for the Nine months FY2014 decreased $2,093,559 to $9,607 from $2,103,166 in the Nine months FY2013 as a result of the legal settlement we entered into with our former bankruptcy attorneys in the amount of $2,095,000 in the Nine months FY 2013.

Our net loss for the Nine months FY2014 increased $710,791 to $9,293,065 from $8,582,274 in the Nine months FY2013, primarily as a result of the recording of $2,095,000 in income from the settlement of a legal dispute noted above offset by the additional legal expenses of $845,000 in FY2013, partially offset by the  increase in the interest expense noted above of $197,000.

Three months ended November 30, 2013 compared to three months ended November 30, 2012

Net revenues for the three months ended November 30, 2013 (the “Third Quarter FY2014”) decreased $362,490 to $852,534 from $1,215,024 in the three months ended November 30, 2012 (the “Third Quarter FY2013”), a decrease of 30%. Our customers typically order on an as needed basis and therefore our sales can fluctuate substantially between periods based on our customers’ needs at a given time.

Cost of goods decreased $303,145 (47%) to $341,503 in the Third Quarter FY2014 from $644,648 in the Third Quarter FY2013. The decrease in cost of goods is primarily a result of the decrease in sales.

Engineering, research and development expenses increased $74,794 (24%) to $387,056 in the Third Quarter FY2014 from $312,262 in the Third Quarter FY 2013. These expenses have decreased in prior periods, but are expected to continue to increase in future periods.

Selling, general and administrative expense decreased $1,649,259 (47%) to $1,847,365 in the Third Quarter FY2014 from $3,496,624 in the Third Quarter FY2013. The decrease is primarily attributable to a decrease in legal expenses of $1,090,000 primarily associated with a legal settlement in the prior year, expenses of approximately $140,000 incurred in moving our production facilities to our headquarters building in the prior year, a decrease in temporary and consulting expense of approximately $120,000, a reduction in marketing expenses of approximately $80,000 and a reduction in payroll and payroll related expenses of approximately $225,000.

Net interest expense in the Third Quarter FY2014 decreased $149,770 (15%) to $859,361 from $1,009,131 in the Third Quarter FY2013 as a result of our increased debt levels, offset by a decrease in the amortization of the debt discount, warrant expense and beneficial conversion feature on the financing completed in the third quarter of FY2012, which was fully amortized and repaid in the first quarter FY2014.

Other income for the Third Quarter FY2014 decreased to $0 from $2,095,000 in the Third Quarter FY2013 as a result of the legal settlement we entered into with our former bankruptcy attorneys in the amount of $2,095,000 in the Third Quarter FY2013.

Our net loss for the Third Quarter FY2014 increased $430,110 to $2,582,751 from $2,152,641 in the Third Quarter FY2013, primarily as a result of the decrease in gross profit due to the decrease in sales, the increase in engineering, research and development expenses, partially offset by the decrease in interest expense, the decrease in legal expense and the decrease in other income.

18

Liquidity and Capital Resources

We had cash of approximately $58,000 and $89,000 as of November 30, 2013, and February 28, 2013, respectively.  We had a working capital deficit at November 30, 2013, and February 28, 2013 of $25,061,693 and $21,986,904, respectively. The working capital deficit includes notes payable and accrued interest to related parties of $19,144,583 and $17,265,466 as of November 30, 2013 and February 28, 2013, respectively.  As of November 30, 2013, we had accounts receivable, net of allowance for doubtful accounts, of $572,652 compared to $279,551 as of February 28, 2013. 

Net cash used in operations for the Nine Months ended November 30, 2013, was $5,228,740, an increase of $1,087,401 from the comparable period in the prior fiscal year. Net cash provided by financing activities during the Nine Months ended November 30, 2013, was $5,197,450, resulting from net proceeds from notes payable.

There were no acquisitions of property and equipment in the Nine Months FY 2014 or the Nine Months FY 2013.

Accrued expenses as of November 30, 2013 increased $671,783 to $2,273,523 from $1,601,740 as of February 28, 2013. Approximately $1,447,000 of accrued expenses is salaries accrued but unpaid to certain employees and ex-employees due to a lack of resources, and approximately $463,000 is accrued but unused vacation time earned by employees.

Net proceeds from the issuance of debt totaled $5,197,450 in the Nine Months FY 2014, compared with $4,174,210 in the Nine Months FY 2013. Net debt proceeds of $82,000 in the Nine Months of FY2014 were from our CEO, and debt repayments totaling $306,250 were made on the $3.5 million financing completed in the third quarter fiscal 2012. As of November 30, 2013, the total amount owing a board member is $13,819,960 plus accrued interest of approximately $4,478,000. If the board member were to demand repayment, we do not currently have the resources to make the payment. We also had net proceeds of $2,500,000 from another board member in the Nine Months of FY2014 from a convertible note we entered into plus an additional $750,000 from a demand note payable. The total amount owing this board member at November 30, 2013 is $1,880,517 net of unamortized discount of $8,590, plus accrued interest of approximately $8,590 on the convertible note and $750,000 plus accrued interest of $9,150 on the demand note.

The Company had a deficit of $26,799,844 in shareholders’ equity as of November 30, 2013, compared to $21,598,286 as of February 28, 2013. The deficit includes approximately $16.2 million of non-cash expenses resulting from charges for stock option and warrant expense for fiscal years 2008 through the first nine months of fiscal year 2014.

Since 2002 substantially all of our revenues from operations have been derived from sales of the AuraGen®. The cash flow generated from our operations to date has not been sufficient to fund our working capital needs, and we cannot predict when operating cash flow will be sufficient to fund working capital needs.

In the past, in order to maintain liquidity we have relied upon external sources of financing, principally equity financing and private indebtedness. We have no bank line of credit and require additional debt or equity financing to fund ongoing operations. The issuance of additional shares of equity in connection with any such financing could dilute the interests of our existing stockholders, and such dilution could be substantial. If we cannot raise needed funds, we would also be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and ultimately our viability as a company.

Capital Transactions

During the quarter ended November 30, 2013, we did not issue any shares of our Common Stock.

During the quarter ended November 30, 2012, we issued 65,789 shares of Common Stock for services rendered valued at $50,000 and 134,807 shares upon conversion of $102,454 of notes payable and accrued interest.

19

Inventories

Inventories consist primarily of components and completed units of the Company’s AuraGen® product.

Early in our AuraGen® program, we determined it was most cost-effective to outsource production of components and subassemblies to volume-oriented manufacturers, rather than produce these parts in house. As a result of this decision, and based on then anticipated sales, we purchased, prior to fiscal 2001, a substantial inventory of components at volume prices. Since sales did not meet such expectations, we have been selling product from this inventory for several years. Management has analyzed its inventories based on its current business plan, current potential orders for future delivery, and pending proposals with prospective customers and has determined that we do not expect to realize all of its inventories within the next year. The net inventories as of November 30, 2013 and February 28, 2013, which are not expected to be realized within a 12-month period have been reclassified as long term.

Most of our inventory consists of a variety of (i) metallic, mechanical components, and (ii) electrical components including metallic chassis to hold the assembled electrical systems.  The vast majority of mechanical components are not aged and most of the electrical components are also not aged.  The components that are aged are related to the prime mover/Generator interface that may not be in demand any longer.

Currently, we offer and ship three different basic models of systems; (i) a 5 kW based systems, (ii) an 8.5 kW based system and (iii) a 16 kW based systems (two 8.5 kW systems configured in tandem back-to-back).  Each of these systems can be configured with different options such as 110 VAC only, 220 VAC only, 24 VDC only, 12 VDC only and AC/DC combinations of the same or different voltages.  In addition, the system can be configured with single phase, split phase or three-phase output.

A number of the mechanical components are common to all three of the above configurations, while others are very specific.  For example, the stators and rotors for the 5 kW systems are different from the 8.5 kW systems, but the housings are the same.  Similarly, the electrical components consist of some parts that are geared for a specific configuration while others are generic and can be used for all of the configurations.   The electrical chassis are also interchangeable between the 5 kW and 8.5 kW configurations. Due to the nature and mix of the product being sold, frequently, the 5 kW electrical systems are upgraded to 8.5 kW systems by replacing some components.

From the above description one can understand that the inventory consists of numerous components and subassemblies but not finished systems; therefore each system that is sold and shipped to a customer is built from some components that are in inventory and others that need to be purchased to be able to configure the required system.

Currently, most of the product being shipped consists of 8.5 kW systems.  These systems are built by using existing inventory subassemblies and parts, including some that can be used for both 5 kW and 8.5 kW systems, and additional parts that are purchased to provide the required configuration.  Typically such systems are built using approximately 20 to 25 percent of existing inventory and approximately 75% of additional parts that are purchased.

However, most of the systems currently being sold to the Korean military consist of 5 kW systems.  They have been purchasing approximately 100 systems per year and have indicated to us that they will continue to do so for the next five years.  To date we have shipped over 500 such systems (in this case 100% of the rotors and stators are used from existing inventory and over 50% of the electrical parts are also from inventory).

In addition to the above, we constantly see demand for different and unique configurations that require the purchase of additional parts.

ITEM 4.  Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Securities and Exchange Act of 1934 Rules 13a-15(f).  Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that the Company's disclosure controls and procedures were effective as of November 30, 2013.

20

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during our fiscal quarter ended November 30, 2013, that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds

 None

ITEM 6.  Exhibits

31.1             Certifications of Principal Executive Officers pursuant to Rule 13a-14 under the Securities Exchange Act of 1934.

31.2             Certifications of Principal Financial Officers pursuant to Rule 13a-14 under the Securities Exchange Act of 1934.

32.1             Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. § 1350, as Adopted Pursuant to § 906 of the Sarbanes-Oxley Act of 2002.

101.INS  XBRL Instance Document

101.SCH  XBRL Schema Document

101.CAL  XBRL Calculation Linkbase Document

101.LAB  Label Linkbase Document

101.PRE  Presentation Linkbase Document

In accordance with SEC Release 33-8238, Exhibit 32.1 is being furnished and not filed.

Furnished herewith, XBRL (Extensive Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Security Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended and otherwise is not subject to liability under these actions.

21

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                  AURA SYSTEMS, INC.          

                  (Registrant)

Date: January 21, 2014                             

By:    /s/ Melvin Gagerman      

Melvin Gagerman

Chief Financial Officer

(Principal Financial and Accounting Officer

and Duly Authorized Officer)

22

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Melvin Gagerman, certify that:

1.           I have reviewed this quarterly report on Form 10-Q  of Aura Systems, Inc.,

2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.            The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.           Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.           Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on our evaluation;

d.           Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.           The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a.           All significant deficiencies and material weaknesses in the design or operation of internal controls which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:  January 21, 2014

By:	/s/ Melvin Gagerman
	Melvin Gagerman
	Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Melvin Gagerman, certify that:

1.           I have reviewed this quarterly report on Form 10-Q of Aura Systems, Inc.,

2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.           The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.           Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.           Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on our evaluation;

d.           Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.           The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a.           All significant deficiencies and material weaknesses in the design or operation of internal controls which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:  January 21, 2014

By:	/s/ Melvin Gagerman
	Melvin Gagerman
	Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Aura Systems, Inc. (the “Company”) on Form 10-Q  for the quarterly period ending August 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Melvin Gagerman, Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods indicated.

Date: January 21, 2014	By:	/s/ Melvin Gagerman
		Melvin Gagerman Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer

XML

INCOME TAXES (Details)	9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
INCOME TAXES [Abstract]
Effective tax rate (in hundredths)	0.00%	0.00%

XML

SEGMENT INFORMATION (Tables)

9 Months Ended

Nov. 30, 2013

SEGMENT INFORMATION [Abstract]

Revenues from customer geographical segments

Total net revenues from customer geographical segments are as follows for the Nine Months ended November 30, 2013 and 2012:

	2013		2012
United States	$	1,451,188	$	1,488,536
Canada		136,097		76,197
Europe		44,503		54,261
Asia		635,780		631,058
Other		8,881		36,444
Total	$	2,276,449	$	2,286,496

XML

INVENTORIES

9 Months Ended

Nov. 30, 2013

INVENTORIES [Abstract]

INVENTORIES

NOTE 3 – INVENTORIES

Inventories, stated at the lower of cost (first in first out), or market consisted of the following:

	November 30, 2013			February 28, 2013
Raw materials	$	1,882,853		$	1,888,831
Finished goods		1,534,778			1,836,960
		3,417,631			3,725,791
Reserve for potential product obsolescence		(1,125,929	)		(1,253,300	)
Discount on long term inventory		(77,502	)		(88,350	)
		2,214,200			2,384,141
Non-current portion		(1,214,200	)		(1,384,141	)
Current portion	$	1,000,000		$	1,000,000

We assessed the net realize-ability and the related potential obsolescence of inventory. In accordance with this assessment, management has recorded a reserve of $1,125,929 and $1,253,300 as of November 30, 2013 and February 28, 2013, respectively. Management has also recorded a discount on long term inventory of $77,502 and $88,350 as of November 30, 2013 and February 28, 2013, respectively.

XML

PROPERTY, PLANT, AND EQUIPMENT (Details) (USD $)	9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Feb. 28, 2013
PROPERTY, PLANT, AND EQUIPMENT [Abstract]
Machinery and equipment	$ 964,111		$ 964,111
Furniture and fixtures	163,302		163,302
Leasehold improvements	0		485,080
Property, plant and equipment, gross	1,127,413		1,612,493
Less accumulated depreciation	(1,115,466)		(1,572,023)
Property, plant, and equipment, net	11,948		40,470
Depreciation expense	$ 28,523	$ 125,783

XML

OTHER CURRENT ASSETS (Details) (USD $)	Nov. 30, 2013	Feb. 28, 2013
OTHER CURRENT ASSETS [Abstract]
Other current assets	$ 254,550	$ 235,034
Vendor advances	$ 173,303	$ 181,910

XML

NOTES PAYABLE (Details) (USD $)	9 Months Ended				9 Months Ended		9 Months Ended				9 Months Ended		9 Months Ended		9 Months Ended				9 Months Ended			9 Months Ended		9 Months Ended		9 Months Ended		9 Months Ended		9 Months Ended		9 Months Ended		9 Months Ended
	Nov. 30, 2013	Feb. 28, 2013	Feb. 29, 2012	Sep. 23, 2011	Nov. 30, 2013 Stock Warrants Granted One [Member]	Sep. 23, 2011 Stock Warrants Granted One [Member]	Nov. 30, 2013 Stock Warrants Granted Two [Member]	Sep. 23, 2011 Stock Warrants Granted Two [Member]	Nov. 30, 2013 Demand notes payable, at 10% and 16% [Member]	Feb. 28, 2013 Demand notes payable, at 10% and 16% [Member]	Nov. 30, 2013 Convertible Promissory Note 7% Due August 2017 Converted [Member]	Feb. 28, 2013 Convertible Promissory Note 7% Due August 2017 Converted [Member]	Nov. 30, 2013 Convertible Promissory Note 7% Due October 2017 Converted [Member]	Feb. 28, 2013 Convertible Promissory Note 7% Due October 2017 Converted [Member]	Nov. 30, 2013 Convertible Promissory Note 7% Due January 2013 Converted [Member]	Feb. 28, 2013 Convertible Promissory Note 7% Due January 2013 Converted [Member]	Nov. 30, 2013 Convertible Promissory Note 7% Due September 2011 converted [Member]	Feb. 28, 2013 7% Convertible promissory note [Member]	Nov. 30, 2013 Senior secured convertible note due March 23, 2013 [Member] Installment	Feb. 28, 2013 Senior secured convertible note due March 23, 2013 [Member]	Sep. 23, 2011 Convertible note payable [Member]	Nov. 30, 2013 Senior secured convertible Note 12% Due June 2013 [Member]	Feb. 28, 2013 Senior secured convertible Note 12% Due June 2013 [Member]	Nov. 30, 2013 Senior secured convertible Note 16% Due June 2014 [Member]	Feb. 28, 2013 Senior secured convertible Note 16% Due June 2014 [Member]	Nov. 30, 2013 May 7 Convertible Note One [Member]	May 07, 2013 May 7 Convertible Note One [Member] Note	Nov. 30, 2013 May 7 Convertible Note Two [Member]	May 07, 2013 May 7 Convertible Note Two [Member] Note	Nov. 30, 2013 May 7 Convertible Note Three [Member]	May 07, 2013 May 7 Convertible Note Three [Member]	Nov. 30, 2013 August 19 Convertible Note [Member]	Aug. 19, 2013 August 19 Convertible Note [Member]	Nov. 30, 2013 June 20 Convertible Note [Member]	Jun. 20, 2013 June 20 Convertible Note [Member]
Note payable [Abstract]
Demand notes payable, at 10% and 16%	$ 1,534,990	$ 3,004,990							$ 1,534,990	$ 3,004,990
Convertible promissory note			1,447,938								770,664	724,056	394,520	373,882	0	350,000
Senior secured convertible note																			0	153,508		2,071,584	0	290,008	0
Notes payable current and long-term portion	5,061,766	4,606,436
Less: Current portion	3,896,582	3,508,498
Long-term portion	1,165,184	1,097,938
Convertible Promissory Note common stock price (in dollars per share)											$ 0.76		$ 0.76		$ 0.76			$ 0.76				$ 0.75		$ 0.75
Notes payable interest rate (in hundredths)									10.00%	12.00%	7.00%		7.00%		7.00%		0.00%	7.00%				12.00%		16.00%									9.50%
Notes payable increased interest rate (in hundredths)																						16.00%		16.00%
Number of monthly installments																			12
Monthly payments of senior secured convertible note																			306,250
Senior secured convertible interest rate (in hundredths)																			0.00%
Prepaid interest on senior secured convertible																			175,000
Common stock exchange ratio	0.85
Convertible Debt [Abstract]
Principal value of convertible notes											1,000,000		500,000		350,000						3,675,000						1,087,000		558,700		750,000		2,500,000		325,000
Convertible debt maturity term																					1 year 6 months						1 year		1 year		1 year		4 years		1 year
Conversion price per share of notes payable (in dollars per share)																					$ 0.75						$ 0.75		$ 0.75		$ 0.75		$ 0.50		$ 0.50
Default conversion price																											$ 0.50		$ 0.50		$ 0.50
Number of common shares entitlement on exercise of warrant one (in shares)						4,900,000		490,000																			1,449,333		744,933		1,000,000		5,000,000		433,334
Exercise price per common share under warrant one (in dollars per share)				$ 0.75		$ 1		$ 0.75																			$ 0.75		$ 0.75		$ 0.75		$ 0.75		$ 0.75
Term of warrant					5 years		5 years																			7 years		7 years		7 years		7 years		7 years
Period of repayment of debt from closing date											5 years		5 years		2 months
Prepaid interest recorded as discount																		402,063			175,000						342,020		175,793		235,985		667,118		63,622
Contingent pay out threshold on gross proceeds																																			5,000,000
Capitalized finance cost																					1,006,482
Discount on shares to be issued upon conversion																					1,790,482
Number of note payables transferred to convertible debt																											4		2
Pre conversion debt principal amount																										1,000,000		550,000
Due date											Aug. 10, 2017		Oct. 02, 2017		Jan. 04, 2013				Mar. 23, 2013			Jun. 15, 2013		Jun. 20, 2014
Maturities of Long-term Debt [Abstract]
2014	0
2015	0
2016	0
2017	3,054,287
Total	$ 3,054,287

XML

ACCRUED EXPENSES (Details) (USD $)	Nov. 30, 2013	Feb. 28, 2013
Accrued expenses [Abstract]
Accrued payroll and related expenses	$ 2,042,474	$ 1,564,496
Accrued rent	145,927	4,292
Accrued interest	79,946	30,867
Other	5,176	2,085
Total	2,273,523	1,601,740
Accrued payroll and related expenses	1,446,640	927,984
Accrued vacation expense	$ 462,687	$ 411,667

XML

GOING CONCERN

9 Months Ended

Nov. 30, 2013

GOING CONCERN [Abstract]

GOING CONCERN

NOTE 2 – GOING CONCERN

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern.  During the Nine Months ended November 30, 2013 and November 30, 2012, the Company incurred losses of $9,293,065 and $8,582,274, respectively and had negative cash flows from operating activities of $5,228,740 and $4,141,339, respectively.

If the Company is unable to generate profits and is unable to continue to obtain financing for its working capital requirements, it may have to curtail its business sharply or cease business altogether.

Substantial additional capital resources will be required to fund continuing expenditures related to our research, development, manufacturing and business development activities.  The Company's continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to retain its current financing, to obtain additional financing, and ultimately to attain profitability.

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that could result from the outcome of this uncertainty.

XML

SHAREHOLDERS' EQUITY (Details) (USD $)	9 Months Ended			9 Months Ended																										9 Months Ended			9 Months Ended						9 Months Ended						9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Sep. 23, 2011	Nov. 30, 2013 Exercise Price Range $0.75 and 80 Months [Member]	Nov. 30, 2013 Exercise Price Range $0.75 and 77 Months [Member]	Nov. 30, 2013 Exercise Price Range $0.75 - $1.00 and 68 Months [Member]	Nov. 30, 2013 Exercise Price Range $1.00 - $1.25 and 34 Months [Member]	Nov. 30, 2013 Exercise Price Range $1.00 and 33 Months [Member]	Nov. 30, 2013 Exercise Price Range $1.50 and 28 Months [Member]	Nov. 30, 2013 Exercise Price Range $0.75 - $1.50 and 25 Months [Member]	Nov. 30, 2013 Exercise Price Range $1.50 and 21 Months [Member]	Nov. 30, 2013 Exercise Price Range $1.50 and 20 Months [Member]	Nov. 30, 2013 Exercise Price Range $1.50 and 17 Months [Member]	Nov. 30, 2013 Exercise Price Range $0.75 - $2.00 and 13 Months [Member]	Nov. 30, 2013 Exercise Price Range $2.00 and 10 Months [Member]	Nov. 30, 2013 Exercise Price Range $0.75 - $2.00 and 7 Months [Member]	Nov. 30, 2013 Exercise Price Range $3.00 and 0.5 Months [Member]	Nov. 30, 2013 Vice President [Member]	Nov. 30, 2013 Other Employee [Member]	Nov. 30, 2013 Minimum [Member] Exercise Price Range $0.75 - $1.00 and 68 Months [Member]	Nov. 30, 2013 Minimum [Member] Exercise Price Range $1.00 - $1.25 and 34 Months [Member]	Nov. 30, 2013 Minimum [Member] Exercise Price Range $0.75 - $1.50 and 25 Months [Member]	Nov. 30, 2013 Minimum [Member] Exercise Price Range $0.75 - $2.00 and 13 Months [Member]	Nov. 30, 2013 Minimum [Member] Exercise Price Range $0.75 - $2.00 and 7 Months [Member]	Nov. 30, 2013 Maximum [Member] Exercise Price Range $0.75 - $1.00 and 68 Months [Member]	Nov. 30, 2013 Maximum [Member] Exercise Price Range $1.00 - $1.25 and 34 Months [Member]	Nov. 30, 2013 Maximum [Member] Exercise Price Range $0.75 - $1.50 and 25 Months [Member]	Nov. 30, 2013 Maximum [Member] Exercise Price Range $0.75 - $2.00 and 13 Months [Member]	Nov. 30, 2013 Maximum [Member] Exercise Price Range $0.75 - $2.00 and 7 Months [Member]	Nov. 30, 2013 Employee Stock Option Plan 2006 [Member]	Nov. 30, 2013 Employee Stock Option Plan 2006 [Member] Minimum [Member]	Nov. 30, 2013 Employee Stock Option Plan 2006 [Member] Maximum [Member]	Nov. 30, 2013 Warrant [Member]	Feb. 28, 2013 Warrant [Member] Exercise Price Range $0.75 and 80 Months [Member]	Nov. 30, 2013 Warrant [Member] Minimum [Member]	Feb. 28, 2013 Warrant [Member] Minimum [Member] Exercise Price Range $0.75 and 80 Months [Member]	Nov. 30, 2013 Warrant [Member] Maximum [Member]	Feb. 28, 2013 Warrant [Member] Maximum [Member] Exercise Price Range $0.75 and 80 Months [Member]	Nov. 30, 2013 Notes Payable and Accrued Interest [Member]	Nov. 30, 2012 Notes Payable and Accrued Interest [Member]	Nov. 30, 2013 Re-price of Prior Issuance [Member]	Nov. 30, 2013 Settlement of Debt Payment Failure [Member]	Nov. 30, 2013 Issuance of Letter of Credit [Member]	Nov. 30, 2012 Issuance of Letter of Credit [Member]	Nov. 30, 2013 Joining Board of Directors [Member]	Nov. 30, 2013 Services Rendered [Member]	Nov. 30, 2012 Services Rendered [Member]	Nov. 30, 2013 Cancellation of Warrants [Member]
Common Stock [Abstract]
Common Stock issued for cash consideration (in shares)		200,000																																							1,833,333	1,266,667	700,000		500,000
Cash consideration received on issuance of Common Stock	$ 0	$ 152,000
Other Significant Noncash Transactions [Line Items]
Liability converted into common shares																																							1,330,112	259,729						297,726	316,000
Common stock issued on conversion of liability (in shares)																																							2,660,225	341,748						595,451	350,000	4,254,250
Common stock issued (in shares)		200,000																																							1,833,333	1,266,667	700,000		500,000
Common stock issued value																																										304,000	168,000		120,000
Debt amount																																										500,000		415,789
Common stock issuable from exercise of warrants (in shares)																																									916,666	1,000,000	700,000		800,000			5,005,000
Exercise price of warrants (in dollars per share)			$ 0.75																																						$ 0.75							$ 0.75
Warrants issued (in shares)																																									916,666	1,000,000	700,000		800,000			5,005,000
Value of warrants issued																																										133,424	93,397		106,739
Weighted Average Exercise Price [Abstract]
Outstanding, Beginning Balance (in dollars per share)																															$ 0.75	$ 1.00
Cancelled (in dollars per share)																														$ 0
Granted (in dollars per share)																														$ 0.75
Outstanding, Ending Balance (in dollars per share)																															$ 0.75	$ 1.00
Aggregate Intrinsic Value [Abstract]
Outstanding, Beginning Balance																														0
Outstanding, Ending Balance																														$ 0
Number of Options [Roll Forward]
Outstanding, Beginning Balance (in shares)																														8,548,000
Cancelled (in shares)																														0
Granted (in shares)																		233,333	7,000											240,333
Outstanding, Ending Balance (in shares)																														8,788,333
Exercise prices for outstanding options and option information [Abstract]
Range of Exercise Price (in dollars per share)																															$ 0.75	$ 1.00
Options Outstanding Number (in shares)																														8,788,333
Weighted Average Remaining Life Options Outstanding																														6 years 1 month 24 days
Weighted Average Exercise Price Options Outstanding (in dollars per share)																														$ 0.79
Weighted Average Remaining Life Exercisable Options																														6 years 3 months
Exercisable Options Number (in shares)																														8,421,666
Weighted Average Exercise Price Exercisable Options (in dollars per share)																														$ 0.79
Number of Shares [Roll Forward]
Beginning Balance (in shares)																																		38,783,290
Granted (in shares)																																	12,262,096
Cancelled (in shares)																																	(5,025,000)
Ending Balance (in shares)	46,020,386			8,893,334	3,368,762	8,756,942	1,220,000	16,722,787	155,000	1,109,198	156,000	704,000	350,642	58,000	725,721	3,650,000	150,000																46,020,386	38,783,290
Exercise Prices [Abstract]
Outstanding, Beginning Balance (in dollars per share)																				$ 0.75	$ 1.00	$ 0.75	$ 0.75	$ 0.75	$ 1.00	$ 1.25	$ 1.50	$ 2.00	$ 2.00						$ 0.75	$ 0.75	$ 3.00	$ 3.00
Granted (in dollars per share)																																	$ 0.75
Cancelled (in dollars per share)																																	$ 0.75
Outstanding, Ending Balance (in dollars per share)				$ 0.75	$ 0.75			$ 1.00	$ 1.50		$ 1.50	$ 1.50	$ 1.50		$ 2.00		$ 3.00			$ 0.75	$ 1.00	$ 0.75	$ 0.75	$ 0.75	$ 1.00	$ 1.25	$ 1.50	$ 2.00	$ 2.00						$ 0.75	$ 0.75	$ 3.00	$ 3.00
Exercise prices for warrants outstanding and warrant information [Abstract]
Range of Exercise Prices (in dollars per share)				$ 0.75	$ 0.75			$ 1.00	$ 1.50		$ 1.50	$ 1.50	$ 1.50		$ 2.00		$ 3.00			$ 0.75	$ 1.00	$ 0.75	$ 0.75	$ 0.75	$ 1.00	$ 1.25	$ 1.50	$ 2.00	$ 2.00						$ 0.75	$ 0.75	$ 3.00	$ 3.00
Stock Warrants Outstanding (in shares)	46,020,386			8,893,334	3,368,762	8,756,942	1,220,000	16,722,787	155,000	1,109,198	156,000	704,000	350,642	58,000	725,721	3,650,000	150,000																46,020,386	38,783,290
Stock Warrants Exercisable (in shares)	46,020,386			8,893,334	3,368,762	8,756,942	1,220,000	16,722,787	155,000	1,109,198	156,000	704,000	350,642	58,000	725,721	3,650,000	150,000
Weighted-Average Remaining Contractual Life				80 months	77 months	68 months	34 months	33 months	28 months	25 months	21 months	20 months	17 months	13 months	10 months	7 months	0 months 15 days
Weighted-Average Exercise Price of Warrants Outstanding (in dollars per share)				$ 0.75	$ 0.75	$ 0.81	$ 1.03	$ 1.00	$ 1.50	$ 1.17	$ 1.50	$ 1.50	$ 1.50	$ 1.78	$ 2.00	$ 1.03	$ 3.00
Weighted-Average Exercise Price of Warrants Exercisable (in dollars per share)				$ 0.75	$ 0.75	$ 0.81	$ 1.03	$ 1.00	$ 1.50	$ 1.17	$ 1.50	$ 1.50	$ 1.50	$ 1.78	$ 2.00	$ 1.03	$ 3.00
Intrinsic Value (in dollars per share)				$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0

XML

CONDENSED BALANCE SHEETS (Unaudited) (USD $)	Nov. 30, 2013	Feb. 28, 2013
Current assets:
Cash and cash equivalents	$ 57,906	$ 89,196
Accounts receivable, net of allowance for doubtful accounts of $50,000 at November 30, 2013 and February 28, 2013	572,652	279,551
Inventory - current	1,000,000	1,000,000
Other current assets	254,550	235,034
Total current assets	1,885,108	1,603,780
Deposits	89,988	61,944
Property, plant, and equipment, net	11,948	40,470
Inventory, non-current, net of allowance for obsolete inventory of $1,203,431 and $1,341,650 at November 30, 2013 and February 28, 2013, respectively	1,214,200	1,384,142
Total assets	3,201,244	3,090,336
Current liabilities:
Accounts payable	1,560,034	1,202,382
Accrued expenses	2,273,523	1,601,740
Customer advances	72,080	12,598
Notes payable	1,534,990	3,004,990
Convertible notes payable, net of discount	2,361,592	503,509
Notes payable and accrued interest- related party	19,144,583	17,265,466
Total current liabilities	26,946,801	23,590,684
Convertible note payable, net of discount	1,165,184	1,097,938
Convertible note payable and accrued interest-related party, net of discount	1,889,103	0
Total liabilities	30,001,088	24,688,623
Commitments and contingencies
Stockholders' deficit:
Common stock, $0.0001 par value; 150,000,000 shares authorized at November 30, 2013 and February 28, 2013; 88,414,499 and 76,604,573 issued and outstanding at November 30, 2013 and February 28, 2013, respectively	8,841	7,660
Additional paid-in capital	403,040,092	398,949,767
Accumulated deficit	(429,848,777)	(420,555,713)
Total stockholders' deficit	(26,799,844)	(21,598,286)
Total liabilities and stockholders' deficit	$ 3,201,244	$ 3,090,336

XML

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (Parenthetical) (USD $)	9 Months Ended
	Nov. 30, 2013
Other Significant Noncash Transactions [Line Items]
Liability converted into common shares (in shares)	4,254,250
Cancellation of warrants to purchase shares of common stock (in shares)	5,005,000
Common stock, Exercise Price (in dollars per share)	$ 0.75
Notes Payable and Accrued Interest [Member]
Other Significant Noncash Transactions [Line Items]
Notes payable and accrued interest were converted	$ 1,330,112
Common stock issued for debt conversion (in shares)	2,660,225
Re-price of Prior Issuance [Member]
Other Significant Noncash Transactions [Line Items]
Common stock issued (in shares)	1,833,333
Warrants issued (in shares)	916,666
Exercise price of warrants (in dollars per share)	$ 0.75
Term of warrant	7 years

XML

SIGNIFICANT CUSTOMERS (Details) (USD $)	9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Significant Customer1 [Member]
Concentration Risk [Line Items]
Percentage sales significant customers (in hundredths)	27.40%	26.00%
Significant Customer2 [Member]
Concentration Risk [Line Items]
Percentage sales significant customers (in hundredths)	24.80%	18.00%
Significant Customer3 [Member]
Concentration Risk [Line Items]
Percentage sales significant customers (in hundredths)	10.00%	17.00%
Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Number of significant customers	3	3
Customer Concentration Risk [Member] | Significant Customer1 [Member]
Concentration Risk [Line Items]
Net accounts receivable from significant customers	$ 173,430	$ 83,388
Customer Concentration Risk [Member] | Significant Customer2 [Member]
Concentration Risk [Line Items]
Net accounts receivable from significant customers	0	419,321
Customer Concentration Risk [Member] | Significant Customer3 [Member]
Concentration Risk [Line Items]
Net accounts receivable from significant customers	$ 194,250	$ 102,585

XML

NOTES PAYABLE (Tables)

9 Months Ended

Nov. 30, 2013

NOTES PAYABLE [Abstract]

Notes payable

Notes payable consisted of the following:

	November 30, 2013		February 28, 2013
Demand notes payable, at 10% and 16%	$	1,534,990	$	3,004,990
Convertible Promissory Note dated August 10, 2012, due August 10, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 10th of each month with the principal payment due on the maturity date.		770,664		724,056
Convertible Promissory Note dated October 2, 2012, due October 2, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 2nd of each month with the principal payment due on the maturity date.		394,520		373,882
Convertible Promissory Note dated November 2, 2012, due January 4, 2013, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 2nd of each month with the principal payment due on the maturity date.		-		350,000
Senior secured convertible note dated September 23, 2011, due March 23, 2013, with 12 monthly payments commencing April 23, 2012 of $306,250 per month. The notes have a stated interest rate of 0%, with prepaid interest of $175,000. Balance net of Beneficial Conversion Feature		-		153,508
Senior secured convertible notes dated May 7, 2013, due June 15, 2013, convertible into shares of our common stock at a price of $0.75 per share. The notes carry an interest rate of 12% with interest due on the last day of the month. If the note is not repaid by the due date, the interest rate increases to 16%.		2,071,584		-
Senior secured convertible notes dated June 20, 2013, due June 20, 2014, convertible into shares of our common stock at a price of $0.75 per share. The notes carry an interest rate of 16% with interest due on the last day of the month. If the note is not repaid by the due date, the interest rate increases to 16%.		290,008		-
		5,061,766		4,606,436
Less: Current portion	$	3,896,582	$	3,508,498
Long-term portion	$	1,165,184	$	1,097,938

Future maturities of notes payable

Future maturities of notes payable at November 30, 2013 are as follows:

Year Ending February 28,
2014	$	-
2015		-
2016		-
2017		3,054,287
Total	$	3,054,287

XML

RELATED PARTY TRANSACTIONS (Details) (USD $)	9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Feb. 28, 2013	Sep. 23, 2011
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	$ 19,144,583		$ 17,265,466
Related party transaction, rate (in hundredths)	10.00%
Interest expense accrued on unsecured notes payable	1,032,647	960,078
Stock issued to related party (in shares)		200,000
Exercise price of warrants (in dollars per share)				$ 0.75
Convertible Secured Notes [Member]
Related Party Transaction [Line Items]
Discount on notes payable				175,000
Debt amount				3,675,000
Members of Board of Directors [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	13,819,960
Members of Board of Directors [Member] | Convertible Secured Notes [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	1,880,517
Discount on notes payable	619,483
Debt amount	2,500,000
Members of Board of Directors [Member] | Unsecured note payable [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	750,000
Related party transaction, date	Oct. 17, 2013
Members of Board of Directors [Member] | Re-price of Prior Issuance [Member]
Related Party Transaction [Line Items]
Stock issued to related party (in shares)	1,833,333
Warrants issued (in shares)	916,666
Exercise price of warrants (in dollars per share)	$ 0.75
Members of Board of Directors [Member] | Settlement of debt payment failure [Member]
Related Party Transaction [Line Items]
Stock issued to related party (in shares)	1,266,667
Warrants issued (in shares)	1,000,000
Exercise price of warrants (in dollars per share)	$ 0.75
Term of warrant	7 years
Members of Board of Directors [Member] | Issuance of Letter of Credit [Member]
Related Party Transaction [Line Items]
Stock issued to related party (in shares)	700,000
Warrants issued (in shares)	700,000
Exercise price of warrants (in dollars per share)	$ 0.75
Debt amount	350,000
Term of warrant	7 years
Members of Board of Directors [Member] | Joining Board of Directors [Member]
Related Party Transaction [Line Items]
Stock issued to related party (in shares)	500,000
Warrants issued (in shares)	800,000
Exercise price of warrants (in dollars per share)	$ 0.75
Term of warrant	7 years
Members of Board of Directors [Member] | Accrued interest [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	4,478,153
Members of Board of Directors [Member] | Accrued interest [Member] | Convertible Secured Notes [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	8,586
Members of Board of Directors [Member] | Accrued interest [Member] | Unsecured note payable [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	9,151
CEO [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	82,000
Related party transaction, date	Apr. 05, 2013
CEO [Member] | Accrued interest [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	$ 5,319

XML

SHAREHOLDERS' EQUITY (Tables)

9 Months Ended

Nov. 30, 2013

SHAREHOLDERS' EQUITY [Abstract]

Stock Option Activity

In September, 2006, our Board of Directors adopted the 2006 Employee Stock Option Plan. Activity in this plan is as follows:

	2006 Plan
	Weighted-Average Exercise Price		Aggregate Intrinsic Value		Number of Options
Outstanding, February 28, 2013	$	0.75-$1.00	$	0.00		8,548,000
Cancelled		-		-		-
Granted	$	0.75	$	0.00		240,333
Outstanding, November 30, 2013	$	0.75-$1.00	$	0.00		8,788,333

Exercise price of options outstanding and options information

The exercise prices for the options outstanding at November 30, 2013, and information relating to these options is as follows:

Options Outstanding								Exercisable Options
Range of Exercise Price		Number		Weighted Average Remaining Life	Weighted Average Exercise Price			Weighted Average Remaining Life	Number		Weighted Average Exercise Price
$	0.75-$1.00		8,788,333	6.15 years		$	0.79	6.25years		8,421,666		$	0.79

Warrants Activity

Activity in issued and outstanding warrants is as follows:

	Number of Shares			Exercise Prices
Outstanding, February 28, 2013		38,783,290		$	0.75-$3.00
Granted		12,262,096		$	0.75
Cancelled/Expired		(5,025,000	)	$	0.75
Outstanding, November 30, 2013		46,020,386		$	0.75-$3.00

Exercise prices for the warrants outstanding and warrant information

The exercise prices for the warrants outstanding at November 30, 2013, and information relating to these warrants is as follows:

Range of Exercise Prices		Stock Warrants Outstanding		Stock Warrants Exercisable		Weighted-Average Remaining Contractual Life	Weighted-Average Exercise Price of Warrants Outstanding		Weighted-Average Exercise Price of Warrants Exercisable		Intrinsic Value
$	0.75		8,893,334		8,893,334	80 months	$	0.75	$	0.75	$	0.00
$	0.75		3,368,762		3,368,762	77 months	$	0.75	$	0.75	$	0.00
$	0.75-$1.00		8,756,942		8,756,942	68 months	$	0.81	$	0.81	$	0.00
$	1.00-$1.25		1,220,000		1,220,000	34 months	$	1.03	$	1.03	$	0.00
$	1.00		16,722,787		16,722,787	33 months	$	1.00	$	1.00	$	0.00
$	1.50		155,000		155,000	28 months	$	1.50	$	1.50	$	0.00
$	0.75-1.50		1,109,198		1,109,198	25 months	$	1.17	$	1.17	$	0.00
$	1.50		156,000		156,000	21 months	$	1.50	$	1.50	$	0.00
$	1.50		704,000		704,000	20 months	$	1.50	$	1.50	$	0.00
$	1.50		350,642		350,642	17 months	$	1.50	$	1.50	$	0.00
$	0.75-$2.00		58,000		58,000	13 months	$	1.78	$	1.78	$	0.00
$	2.00		725,721		725,721	10 months	$	2.00	$	2.00	$	0.00
$	0.75-2.00		3,650,000		3,650,000	7 months	$	1.03	$	1.03	$	0.00
$	3.00		150,000		150,000	.5 months	$	3.00	$	3.00	$	0.00
			46,020,386		46,020,386

XML

ACCOUNTING POLICIES

9 Months Ended

Nov. 30, 2013

ACCOUNTING POLICIES [Abstract]

ACCOUNTING POLICIES

NOTE 1 - ACCOUNTING POLICIES

Accounting principles

In the opinion of management, the accompanying balance sheets and related interim statements of income and comprehensive income, and cash flows include all adjustments, consisting only of normal recurring items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s 2013 Form 10-K filed on June 12, 2013 with the U.S. Securities and Exchange Commission.

Estimates

The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Recently Issued Accounting Pronouncements

Accounting Standards Update No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists: An unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The assessment of whether a deferred tax asset is available is based on the unrecognized tax benefit and deferred tax asset that exist at the reporting date and should be made presuming disallowance of the tax position at the reporting date. For example, an entity should not evaluate whether the deferred tax asset expires before the statute of limitations on the tax position or whether the deferred tax asset may be used prior to the unrecognized tax benefit being settled. The amendments in this Update do not require new recurring disclosures. ASU Topic No. 2013 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

Accounting Standards Update No. 2013-05, Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity: This ASU addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. ASU Topic No. 2013-05 is effective for our fiscal year 2014, although early adoption is permitted. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

In March 2013, the FASB issued guidance on a parent’s accounting for the cumulative translation adjustment upon derecognition of a subsidiary or group of assets within a foreign entity. This new guidance requires that the parent release any related cumulative translation adjustment into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided. The new guidance will be effective for the Company beginning July 1, 2014. The adoption of this standard is not expected to have a material impact on the Company’s financial statements.

In February 2013, the FASB issued ASU No. 2013-02, which amends the authoritative accounting guidance under ASC Topic 220 Comprehensive Income.  The amendments do not change the current requirements for reporting net income or other comprehensive income in financial statements.  However, the amendments require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.  In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period.  For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about those amounts.  The amendments in this update are effective prospectively for reporting periods beginning after December 15, 2013.  Early adoption is permitted.  Adoption of this update is not expected to have a material effect on the Company’s consolidated results of operations or financial condition.

Reclassifications

Certain reclassifications have been made to the comparative financial statements to conform to the current period presentation.

XML

CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) (USD $)	Nov. 30, 2013	Feb. 28, 2013
Current assets:
Allowance for doubtful accounts	$ 50,000	$ 50,000
Allowance for obsolete inventory	$ 1,203,431	$ 1,341,650
Stockholders' deficit:
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	88,414,499	76,604,573
Common stock, shares outstanding (in shares)	88,414,499	76,604,573

XML

SIGNIFICANT CUSTOMERS

9 Months Ended

Nov. 30, 2013

SIGNIFICANT CUSTOMERS [Abstract]

SIGNIFICANT CUSTOMERS

NOTE 11 – SIGNIFICANT CUSTOMERS

Concentration Risk

In the Nine Months ended November 30, 2013, we sold AuraGen related products to three significant customers whose sales comprised 27.4%, 24.8% and 10.0% of net sales, respectively. Net accounts receivable from these customers at November 30, 2013 were $173,430, $0 and $194,250 respectively. These customers are not related to or affiliated with us. In the nine months ended November 30, 2012, we sold AuraGen related products to three significant customers whose sales comprised 26%, 18% and 17% of net sales, respectively. Net accounts receivable from these customers at November 30, 2012 were $83,388, $419,321and $102,585 respectively. These customers are not related to or affiliated with us.

XML

Document and Entity Information	9 Months Ended
	Nov. 30, 2013	Jan. 06, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	AURA SYSTEMS INC
Entity Central Index Key	0000826253
Current Fiscal Year End Date	--02-28
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		88,414,499
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Nov. 30, 2013

XML

RELATED PARTY TRANSACTIONS

9 Months Ended

Nov. 30, 2013

RELATED PARTY TRANSACTIONS [Abstract]

RELATED PARTY TRANSACTIONS

NOTE 12 – RELATED PARTIES TRANSACTIONS

At November 30, 2013, the balance in Notes Payable and accrued interest-related party, current, includes $13,819,960 of unsecured notes payable plus accrued interest of $4,478,153 to a member of our Board of Directors, payable on demand, bearing interest at a rate of 10% per annum. During the Nine Months ended November 30, 2013 and November 30, 2012, interest amounting to $1,032,647 and $960,078 respectively, was incurred on these notes. The balance also includes $82,000 of unsecured notes payable plus accrued interest of $5,319 to our CEO pursuant to a demand note entered into on April 5, 2013 and an unsecured note payable to another member of our Board of Directors in the amount of $750,000 plus accrued interest of $9,151 pursuant to a 10% demand note payable entered into on October 17, 2013. At November 30, 2013, the balance in Convertible note payable and accrued interest-related party, long term, includes $1,880,517 of secured notes payable net of discounts of $619,483 plus accrued interest of $8,586 to another member of our Board of Directors. The Company also issued the following stock and warrants to this board member: 1,833,333 shares of our common stock and 916,666 7 year warrants with an exercise price of $0.75 as a re-pricing of a previous issuance made in December 2012, 1,266,667 shares of our common stock and 1,000,000 7 year warrants with an exercise price of $0.75 for failure to repay a $500,000 note when due, 700,000 shares of our common stock and 700,000 7 year warrants with an exercise price of $0.75 for issuing a $350,000 letter of credit on Aura’s behalf, 500,000 shares of our common stock and 800,000 7 year warrants with an exercise price of $0.75 for joining Aura’s Board of Directors, and 5,000,000 7 year warrants attached to the $2,500,000 convertible note which includes the unpaid $500,000 note referred to above.

XML

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended				9 Months Ended
	Nov. 30, 2013		Nov. 30, 2012		Nov. 30, 2013		Nov. 30, 2012
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) [Abstract]
Net Revenues	$ 852,534		$ 1,215,024		$ 2,276,449		$ 2,286,496
Cost of goods sold	341,503		644,648		973,458		1,104,674
Gross Profit	511,031		570,376		1,302,991		1,181,822
Expenses
Engineering, research and development expenses	387,056		312,262		1,090,756		1,008,954
Selling, general and administrative expenses	1,847,365		3,496,624		6,686,790		8,024,082
Total costs and expenses	2,234,422		3,808,886		7,777,546		9,033,036
Loss from operations	(1,723,391)		(3,238,510)		(6,474,555)		(7,851,214)
Other (income) and expense:
Interest expense, net	859,361		1,009,131		3,031,227		2,834,226
Gain on settlement of debt	0		0		(203,110)		0
Other (income) expense, net	0		(2,095,000)		(9,607)		(2,103,166)
Total other (income) expense	859,361		(1,085,869)		2,818,510		731,060
Net Loss	$ (2,582,751)		$ (2,152,641)		$ (9,293,065)		$ (8,582,274)
Total basic and diluted loss per share (in dollars per share)	$ (0.03)		$ (0.03)		$ (0.11)		$ (0.12)
Weighted average shares used to compute basic and diluted income (loss) per share (in shares)	88,414,499	[1]	72,750,310	[1]	83,517,143	[1]	72,381,581	[1]

[1] Weighted average number of shares used to compute basic and diluted loss per share is the same since the effect of the dilutive securities is anti-dilutive.

XML

NOTES PAYABLE

9 Months Ended

Nov. 30, 2013

NOTES PAYABLE [Abstract]

NOTES PAYABLE

NOTE 6 – NOTES PAYABLE

Notes payable consisted of the following:

	November 30, 2013		February 28, 2013
Demand notes payable, at 10% and 16%	$	1,534,990	$	3,004,990
Convertible Promissory Note dated August 10, 2012, due August 10, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 10th of each month with the principal payment due on the maturity date.		770,664		724,056
Convertible Promissory Note dated October 2, 2012, due October 2, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 2nd of each month with the principal payment due on the maturity date.		394,520		373,882
Convertible Promissory Note dated November 2, 2012, due January 4, 2013, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 2nd of each month with the principal payment due on the maturity date.		-		350,000
Senior secured convertible note dated September 23, 2011, due March 23, 2013, with 12 monthly payments commencing April 23, 2012 of $306,250 per month. The notes have a stated interest rate of 0%, with prepaid interest of $175,000. Balance net of Beneficial Conversion Feature		-		153,508
Senior secured convertible notes dated May 7, 2013, due June 15, 2013, convertible into shares of our common stock at a price of $0.75 per share. The notes carry an interest rate of 12% with interest due on the last day of the month. If the note is not repaid by the due date, the interest rate increases to 16%.		2,071,584		-
Senior secured convertible notes dated June 20, 2013, due June 20, 2014, convertible into shares of our common stock at a price of $0.75 per share. The notes carry an interest rate of 16% with interest due on the last day of the month. If the note is not repaid by the due date, the interest rate increases to 16%.		290,008		-
		5,061,766		4,606,436
Less: Current portion	$	3,896,582	$	3,508,498
Long-term portion	$	1,165,184	$	1,097,938

CONVERTIBLE DEBT

On September 23, 2011, the Company entered into a purchase agreement to sell convertible notes with a total principal value of $3,675,000 and warrants to purchase shares of common stock to an investment fund managed by MDB Capital Group.  The notes have a 1.5 year maturity date and are convertible into shares of common stock at the initial conversion price of $0.75 per share.  The warrants entitle the investors to acquire 4,900,000 and 490,000 shares and have an initial exercise price of $1 and $0.75 per share, respectively, and have a 5 year term. The proceeds of Convertible note were assigned between warrants and convertible note per ASC 470-20. The company recorded $175,000 as a discount (prepaid interest), $1,006,482 as capitalized financing cost and a discount of $1,790,482 on shares to be issued upon conversion of the note into equity. This discount (prepaid interest), capitalized finance cost and discount will be amortized over the life of the note. The notes were repaid in full in March 2013 and the Company then entered into an exchange agreement with the note holders whereby the outstanding warrants held by the investors, which carried an exercise price of $0.75 per share and would expire on September 22, 2016, were exchanged for our Common Stock at a ratio of 0.85 shares of common stock for each warrant outstanding.

On May 7, 2013, the Company transferred 4 notes payable with a total principal value of $1,000,000 together with accrued interest, and consulting fees to a senior secured convertible note with a principal value of $1,087,000 (“new note”) and warrants to Kenmont Capital Partners (the “holder”). The new note has a 1 year maturity date and is convertible into shares of common stock at the conversion price of $0.75 per share, provided, that the Conversion Price shall automatically be reset to $0.50 per share on June 15, 2013 if a Qualified Financing has not occurred on or prior to that date. The warrants entitle the holder to acquire 1,449,333 shares and have an initial exercise price of $0.75 per share, and have a 7 year term. The Company recorded $342,020 as a discount, which will be amortized over the life of the note.

On May 7, 2013, the Company transferred 2 note payables with a total principal value of $550,000 together with accrued interest to a senior secured convertible note with a principal value of $558,700 (“new note”) and warrants to LPD Investments, Ltd. (the “holder”). The new note has a 1 year maturity date and is convertible into shares of common stock at the conversion price of $0.75 per share, provided, that the Conversion Price shall automatically be reset to $0.50 per share on June 15, 2013 if a Qualified Financing has not occurred on or prior to that date. The warrants entitle the holder to acquire 744,933 shares and have an initial exercise price of $0.75 per share, and have a 7 year term. The Company recorded $175,793 as a discount, which will be amortized over the life of the note.

On May 7, 2013, the Company entered into an agreement with an individual (the “holder”) for the sale of $750,000 of secured convertible note payable (the “Note”) and warrants to the holder. The Note has a 1 year maturity date and is convertible into shares of common stock at the conversion price of $0.75 per share, provided, that the Conversion Price shall automatically be reset to $0.50 per share on June 15, 2013 if a Qualified Financing has not occurred on or prior to that date. The warrants entitle the holder to acquire 1,000,000 shares and have an initial exercise price of $0.75 per share, and have a 7 year term. The Company recorded $235,985 as a discount, which will be amortized over the life of the note.

On June 20, 2013, the Company entered into an agreement with four individuals (the “holders”) for the sale of $325,000 of secured convertible notes payable (the “Notes”) and warrants to the holders. The Notes have a 1 year maturity date and are convertible into shares of common stock at the conversion price of $0.50 per share. If the Company receives no less than $5,000,000 in aggregate gross proceeds from the sale of equity securities of the Company in one or series of related transactions after June 20, 2013 (“the Qualified Financing”), the Company shall deliver to each Holder a written offer to issue and sell to or exchange with such Holder such number of securities as is equal to the quotient of (x) the conversion balance of the Note divided by (y) 100% of the purchase price of the primary securities offered to investors pursuant to the Qualified Financing. The warrants entitle the holders to acquire 433,334 shares and have an initial exercise price of $0.75 per share, and have a 7 year term. The Company recorded $63,622 as a discount, which will be amortized over the life of the notes.

On August 19, 2013, the Company entered into an agreement with a member of its Board of Directors for the sale of $2,500,000 of convertible notes payable (the “Notes”) and warrants to the holder. The notes carry a base interest rate of 9.5%, have a 4 year maturity date and are convertible into shares of common stock at the conversion price of $0.50 per share. The warrants entitle the holder to acquire 5,000,000 shares and have an initial exercise price of $0.75 per share and have a 7 year term. The Company recorded $667,118 as a discount, which will be amortized over the life of the note.

Future maturities of notes payable at November 30, 2013 are as follows:

Year Ending February 28,
2014	$	-
2015		-
2016		-
2017		3,054,287
Total	$	3,054,287

CONVERTIBLE PROMISSORY NOTES

At February 28, 2013, the three other convertible promissory note payable amounted to $1,447,938, net of discounts of $402,063. The convertible notes (the “Notes”) bear interest at 7% per annum, and are convertible into common stock of the Company at $0.76 per share (as well as variable conversion rates as described below). The notes are due on August 10, 2017, October 2, 2017, and January 4, 2013 and are unsecured. On May 7, 2013, the note due on January 4, 2013 was converted into a portion of the note due June 15, 2013, which carries an interest rate of 12%.

7% Convertible Promissory Notes:

On August 10, 2012 the Company entered into an agreement with the individual (the “holder”) for the sale of $1,000,000 of unsecured Convertible Promissory Note (the “Note”) to the holder. The Convertible Promissory Note balance together with all accrued interest thereon shall be due and payable on August 10, 2017 and the annual interest rate is 7% per annum and is due to be repaid 5 years from the closing date.  The Note holder will receive interest on the unpaid principal amount payable monthly in arrears on the tenth day of each calendar month commencing September 10, 2012. Interest shall be computed on the actual number of days elapsed over a 360-day year. The Holder has the right from and after the Date of Issuance, and until any time until the Convertible promissory note is fully paid, to convert any outstanding and unpaid principal portion of the Convertible promissory note into shares of Common Stock. The company recorded $310,723 as a debt discount, which will be amortized over the life of the note.

On October 2, 2012 the Company entered into an agreement with the individual (the “holder”) for the sale of $500,000 of unsecured Convertible Promissory Note (the “Note”) to the holder. The Convertible Promissory Note balance together with all accrued interest thereon shall be due and payable on October 2, 2017 and the annual interest rate is 7% per annum and is due to be repaid 5 years from the closing date.  The Note holder will receive interest on the unpaid principal amount payable monthly in arrears on the second day of each calendar month commencing November 2, 2012. Interest shall be computed on the actual number of days elapsed over a 360-day year. The Holder has the right from and after the Date of Issuance, and until any time until the Convertible promissory note is fully paid, to convert any outstanding and unpaid principal portion of the Convertible promissory note into shares of Common Stock. The company recorded $137,583 as a debt discount, which will be amortized over the life of the note.

On November 2, 2012 the Company entered into an agreement with the individual (the “holder”) for the sale of $350,000 of unsecured Convertible Promissory Note (the “Note”) to the holder. The Convertible Promissory Note balance together with all accrued interest thereon shall be due and payable on January 4, 2013 and the annual interest rate is 7% per annum and is due to be repaid 2 months from the closing date.  The Note holder will receive interest on the unpaid principal amount payable monthly in arrears on the second day of each calendar month commencing December 2, 2012. Interest shall be computed on the actual number of days elapsed over a 360-day year. The Holder has the right from and after the Date of Issuance, and until any time until the Convertible promissory note is fully paid, to convert any outstanding and unpaid principal portion of the Convertible promissory note into shares of Common Stock. On May 7, 2013, this note was converted into a portion of the note due June 15, 2013, which carries an interest rate of 12%.

The Convertible Notes have a variable conversion price. If, at any time while the Notes remain outstanding, the Company issues or sells any Convertible Securities and the lowest price per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof is less than the then Conversion Price of the Notes (such lower price, the "Dilutive Price"), then the Conversion Price of these Notes shall be adjusted to reflect such Dilutive Price. Such adjustment shall be made upon the issuance or sale of the Convertible Security bearing a dilutive price. In the event of default for the Notes, the amount of principal and interest not paid when due becomes immediately due and payable.

XML

PROPERTY, PLANT, AND EQUIPMENT

9 Months Ended

Nov. 30, 2013

PROPERTY, PLANT, AND EQUIPMENT [Abstract]

PROPERTY, PLANT, AND EQUIPMENT

NOTE 5 – PROPERTY, PLANT, AND EQUIPMENT

Property, plant, and equipment consisted of the following:

	November 30, 2013			February 28, 2013
Machinery and equipment	$	964,111		$	964,111
Furniture and fixtures		163,302			163,302
Leasehold improvements		-			485,080
		1,127,413			1,612,493
Less accumulated depreciation		(1,115,466	)		(1,572,023	)
Property, plant and equipment, net	$	11,947		$	40,470

Depreciation expense was $28,523 and $125,783 for the Nine Months ended November 30, 2013 and November 30, 2012, respectively. The Company disposed of all of its leasehold improvements in the third quarter when we moved to a new facility. The assets were fully amortized and there was no gain or loss on the disposition.

XML

ACCRUED EXPENSES (Tables)

9 Months Ended

Nov. 30, 2013

ACCRUED EXPENSES [Abstract]

Accrued expenses

Accrued expenses consisted of the following:

	November 30, 2013		February 28, 2013
Accrued payroll and related expenses	$	2,042,474	$	1,564,496
Accrued rent		145,927		4,292
Accrued interest		79,946		30,867
Other		5,176		2,085
Total	$	2,273,523	$	1,601,740

XML

ACCOUNTING POLICIES (Policies)

9 Months Ended

Nov. 30, 2013

ACCOUNTING POLICIES [Abstract]

Estimates

Estimates

The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

Accounting Standards Update No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists: An unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The assessment of whether a deferred tax asset is available is based on the unrecognized tax benefit and deferred tax asset that exist at the reporting date and should be made presuming disallowance of the tax position at the reporting date. For example, an entity should not evaluate whether the deferred tax asset expires before the statute of limitations on the tax position or whether the deferred tax asset may be used prior to the unrecognized tax benefit being settled. The amendments in this Update do not require new recurring disclosures. ASU Topic No. 2013 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

Accounting Standards Update No. 2013-05, Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity: This ASU addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. ASU Topic No. 2013-05 is effective for our fiscal year 2014, although early adoption is permitted. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

In March 2013, the FASB issued guidance on a parent’s accounting for the cumulative translation adjustment upon derecognition of a subsidiary or group of assets within a foreign entity. This new guidance requires that the parent release any related cumulative translation adjustment into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided. The new guidance will be effective for the Company beginning July 1, 2014. The adoption of this standard is not expected to have a material impact on the Company’s financial statements.

In February 2013, the FASB issued ASU No. 2013-02, which amends the authoritative accounting guidance under ASC Topic 220 Comprehensive Income.  The amendments do not change the current requirements for reporting net income or other comprehensive income in financial statements.  However, the amendments require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.  In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period.  For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about those amounts.  The amendments in this update are effective prospectively for reporting periods beginning after December 15, 2013.  Early adoption is permitted.  Adoption of this update is not expected to have a material effect on the Company’s consolidated results of operations or financial condition.

Reclassifications

Reclassifications

Certain reclassifications have been made to the comparative financial statements to conform to the current period presentation.

XML

INCOME TAXES

9 Months Ended

Nov. 30, 2013

INCOME TAXES [Abstract]

INCOME TAXES

NOTE 9 –INCOME TAXES

Our effective tax rates were approximately 0.0% for the Nine Months ended November 30, 2013 and 2012. Our effective tax rate was lower than the U.S. federal statutory rate primarily due to the fact that we record a full valuation allowance against our deferred tax assets, which is primarily comprised of net operating losses.

XML

ACCRUED EXPENSES

9 Months Ended

Nov. 30, 2013

ACCRUED EXPENSES [Abstract]

ACCRUED EXPENSES

NOTE 7 - ACCRUED EXPENSES

Accrued expenses consisted of the following:

	November 30, 2013		February 28, 2013
Accrued payroll and related expenses	$	2,042,474	$	1,564,496
Accrued rent		145,927		4,292
Accrued interest		79,946		30,867
Other		5,176		2,085
Total	$	2,273,523	$	1,601,740

Accrued payroll and related expenses consisted primarily of salaries accrued but not paid to certain employees. As of November 30, 2013 and February 28, 2013, these amounts total $1,446,640 and $927,984, respectively. Also included in this amount is accrued vacation expense of $462,687 and $411,667 at November 30, 2013 and February 28, 2013, respectively.

XML

SHAREHOLDERS' EQUITY

9 Months Ended

Nov. 30, 2013

SHAREHOLDERS' EQUITY [Abstract]

SHAREHOLDERS' EQUITY

NOTE 8–SHAREHOLDERS’ EQUITY

Common Stock

During the Nine Months ended November 30, 2013, $1,330,112 of notes payable and accrued interest were converted into 2,660,225 shares of common stock, 595,451 shares of common stock were issued for services and expenses related to the notes valued at $297,726, 1,833,333 shares of common stock were issued to re-price a prior issuance of stock in December 2012, 1,266,667 shares valued at $304,000 and 1,000,000 warrants valued at $133,424 were issued as a settlement for failure to repay a $500,000 note when due, 700,000 shares valued at $168,000 and 700,000 warrants valued at $93,397 were issued as consideration for issuing a letter of credit for $350,000 on Aura’s behalf, 500,000 shares valued at $120,000 and 800,000 warrants valued at $106,739 were issued to an individual as consideration for joining Aura’s Board of Directors and 4,254,250 shares of common stock were issued in exchange for the cancellation of warrants to purchase 5,005,000 shares of common stock at an exercise price of $0.75 per share which would have expired on September 22, 2016.

During the nine months ended November 30, 2012, we issued 415,789 shares of Common Stock for services rendered valued at $316,000, 200,000 shares of common stock for consideration of $152,000, and 341,748 shares upon conversion of $259,729 of notes payable and accrued interest.

Employee Stock Options

During the Nine Months ended November 30, 2013 we granted 233,333 options as a performance bonus to our Vice-President of sales and 7,000 options to other employees.

In September, 2006, our Board of Directors adopted the 2006 Employee Stock Option Plan. Activity in this plan is as follows:

	2006 Plan
	Weighted-Average Exercise Price		Aggregate Intrinsic Value		Number of Options
Outstanding, February 28, 2013	$	0.75-$1.00	$	0.00		8,548,000
Cancelled		-		-		-
Granted	$	0.75	$	0.00		240,333
Outstanding, November 30, 2013	$	0.75-$1.00	$	0.00		8,788,333

The exercise prices for the options outstanding at November 30, 2013, and information relating to these options is as follows:

Options Outstanding								Exercisable Options
Range of Exercise Price		Number		Weighted Average Remaining Life	Weighted Average Exercise Price			Weighted Average Remaining Life	Number		Weighted Average Exercise Price
$	0.75-$1.00		8,788,333	6.15 years		$	0.79	6.25years		8,421,666		$	0.79

Warrants

Activity in issued and outstanding warrants is as follows:

	Number of Shares			Exercise Prices
Outstanding, February 28, 2013		38,783,290		$	0.75-$3.00
Granted		12,262,096		$	0.75
Cancelled/Expired		(5,025,000	)	$	0.75
Outstanding, November 30, 2013		46,020,386		$	0.75-$3.00

T

he exercise prices for the warrants outstanding at November 30, 2013, and information relating to these warrants is as follows:

Range of Exercise Prices		Stock Warrants Outstanding		Stock Warrants Exercisable		Weighted-Average Remaining Contractual Life	Weighted-Average Exercise Price of Warrants Outstanding		Weighted-Average Exercise Price of Warrants Exercisable		Intrinsic Value
$	0.75		8,893,334		8,893,334	80 months	$	0.75	$	0.75	$	0.00
$	0.75		3,368,762		3,368,762	77 months	$	0.75	$	0.75	$	0.00
$	0.75-$1.00		8,756,942		8,756,942	68 months	$	0.81	$	0.81	$	0.00
$	1.00-$1.25		1,220,000		1,220,000	34 months	$	1.03	$	1.03	$	0.00
$	1.00		16,722,787		16,722,787	33 months	$	1.00	$	1.00	$	0.00
$	1.50		155,000		155,000	28 months	$	1.50	$	1.50	$	0.00
$	0.75-1.50		1,109,198		1,109,198	25 months	$	1.17	$	1.17	$	0.00
$	1.50		156,000		156,000	21 months	$	1.50	$	1.50	$	0.00
$	1.50		704,000		704,000	20 months	$	1.50	$	1.50	$	0.00
$	1.50		350,642		350,642	17 months	$	1.50	$	1.50	$	0.00
$	0.75-$2.00		58,000		58,000	13 months	$	1.78	$	1.78	$	0.00
$	2.00		725,721		725,721	10 months	$	2.00	$	2.00	$	0.00
$	0.75-2.00		3,650,000		3,650,000	7 months	$	1.03	$	1.03	$	0.00
$	3.00		150,000		150,000	.5 months	$	3.00	$	3.00	$	0.00
			46,020,386		46,020,386

XML

SEGMENT INFORMATION

9 Months Ended

Nov. 30, 2013

SEGMENT INFORMATION [Abstract]

SEGMENT INFORMATION

NOTE 10 - SEGMENT INFORMATION

We are a United States based company providing advanced technology products to various industries. The principal markets for our products are North America, Europe, and Asia. All of our operating long-lived assets are located in the United States. We operate in one segment.

Total net revenues from customer geographical segments are as follows for the Nine Months ended November 30, 2013 and 2012:

	2013		2012
United States	$	1,451,188	$	1,488,536
Canada		136,097		76,197
Europe		44,503		54,261
Asia		635,780		631,058
Other		8,881		36,444
Total	$	2,276,449	$	2,286,496

XML

SEGMENT INFORMATION (Details) (USD $)	9 Months Ended
	Nov. 30, 2013 Segment	Nov. 30, 2012
Segment Reporting , Revenue Reconciling Item [Line Items]
Number of operating segments	1
Revenues from customer geographical segments [Abstract]
United States	$ 1,451,188	$ 1,488,536
Total	2,276,449	2,286,496
Canada [Member]
Revenues from customer geographical segments [Abstract]
Foreign countries	136,097	76,197
Europe [Member]
Revenues from customer geographical segments [Abstract]
Foreign countries	44,503	54,261
Asia [Member]
Revenues from customer geographical segments [Abstract]
Foreign countries	635,780	631,058
Other [Member]
Revenues from customer geographical segments [Abstract]
Foreign countries	$ 8,881	$ 36,444

XML

PROPERTY, PLANT, AND EQUIPMENT (Tables)

9 Months Ended

Nov. 30, 2013

PROPERTY, PLANT, AND EQUIPMENT [Abstract]

Property, plant and equipment

Property, plant, and equipment consisted of the following:

	November 30, 2013			February 28, 2013
Machinery and equipment	$	964,111		$	964,111
Furniture and fixtures		163,302			163,302
Leasehold improvements		-			485,080
		1,127,413			1,612,493
Less accumulated depreciation		(1,115,466	)		(1,572,023	)
Property, plant and equipment, net	$	11,947		$	40,470

XML

GOING CONCERN (Details) (USD $)	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
GOING CONCERN [Abstract]
Net Loss	$ (2,582,751)	$ (2,152,641)	$ (9,293,065)	$ (8,582,274)
Cash flows from operating activities			$ (5,228,740)	$ (4,141,339)

XML

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Cash flow from operating activities:
Net Loss	$ (9,293,065)	$ (8,582,274)
Adjustments to reconcile Net loss to net cash used in operating activities
Depreciation Expense	28,523	125,783
Bad debt expense	0	(4,227)
Amortization of debt discount	725,935	1,806,354
(Gain) Loss on settlement of debt	(203,110)	0
Fair market value of warrants issued for services	333,559	0
Stock issued for services	889,726	316,000
Provision for inventory obsolescence	(138,219)	(193,972)
Amortization of prepaid shares	0	393,328
Fair market value of stock options granted	256,680	204,961
(Increase) decrease in:
Accounts receivable	(293,101)	58,304
Inventory	308,161	357,486
Other current assets and deposit	(47,560)	(248,075)
Increase (decrease) in:
Accounts payable, customer deposit and accrued expenses	2,203,732	1,624,993
Net cash used in operations	(5,228,740)	(4,141,339)
Financing activities:
Issuance of common stock	0	152,000
Proceeds from notes payable	1,171,000	2,671,000
Payments on notes payable	(170,000)	0
Proceeds from convertible notes payable	1,170,700	0
Payments on convertible notes payable	(306,250)	(2,143,750)
Proceeds from notes payable-related party, net	3,332,000	3,494,960
Net cash provided by financing activities:	5,197,450	4,174,210
Net increase (decrease) in cash & cash equivalents	(31,290)	32,871
Cash and cash equivalents at beginning of period	89,196	6,260
Cash and cash equivalents at end of period	57,906	39,131
Cash paid during the period for:
Interest	124,558	25,780
Income taxes	$ 0	$ 0

XML

OTHER CURRENT ASSETS

9 Months Ended

Nov. 30, 2013

OTHER CURRENT ASSETS [Abstract]

OTHER CURRENT ASSETS

NOTE 4 – OTHER CURRENT ASSETS

Other assets of $254,550 and $235,034 are primarily comprised of vendor advances of $173,303 and $181,910 as of November 30, 2013 and February 28, 2013.

XML

INVENTORIES (Details) (USD $)	Nov. 30, 2013	Feb. 28, 2013
INVENTORIES [Abstract]
Raw materials	$ 1,882,853	$ 1,888,831
Finished goods	1,534,778	1,836,960
Inventory gross current and noncurrent portion	3,417,631	3,725,791
Reserve for potential product obsolescence	(1,125,929)	(1,253,300)
Discount on long term inventory	(77,502)	(88,350)
Total inventory, net	2,214,200	2,384,141
Non-current portion	(1,214,200)	(1,384,142)
Current portion	$ 1,000,000	$ 1,000,000

XML

INVENTORIES (Tables)

9 Months Ended

Nov. 30, 2013

INVENTORIES [Abstract]

Inventories

Inventories, stated at the lower of cost (first in first out), or market consisted of the following:

	November 30, 2013			February 28, 2013
Raw materials	$	1,882,853		$	1,888,831
Finished goods		1,534,778			1,836,960
		3,417,631			3,725,791
Reserve for potential product obsolescence		(1,125,929	)		(1,253,300	)
Discount on long term inventory		(77,502	)		(88,350	)
		2,214,200			2,384,141
Non-current portion		(1,214,200	)		(1,384,141	)
Current portion	$	1,000,000		$	1,000,000